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Abstract
Prolonged intermittent exercise, in the guise of simulated soccer match play, has the 
potential to elevate the production of reactive oxygen species and leave participants 
susceptible to oxidative stress, subsequent muscle damage (Thompson et a l , 2001) 
and muscle soreness (Wadsworth et al., 2004). Supplementation with
phosphatidylserine (PS), a primary constituent of the inner membranes of neurones, 
has been shown to enhance cognitive function in the elderly (Pepu et a l , 1996; 
Blokland et a l , 1999) and inhibit the exercise-induced release of stress hormones 
(Monteleone et a l , 1990; Monteleone et a l , 1992; Fahey and Pearl, 1998). In 
addition to a myriad of membrane functions, in-vitro studies have demonstrated that 
PS has the potential to act as an antioxidant (Latorraca et a l , 1993; Dacaranhe and 
Terao, 2001). Consequently, it is plausible that exogenous supplementation with PS 
may provide additional defence against the oxidative stress caused by exercise; 
however this action has yet to be explored. Therefore, the aim of the current study 
was to investigate the effect of chronic soybean-derived PS (S-PS) supplementation 
on muscle damage, delayed onset muscle soreness, and the body’s response to 
prolonged intermittent exercise.
Sixteen familiarised male subjects were administered with either 750 mg-day*1 of S- 
PS or a glucose placebo, in a double-blind randomised fashion, for 10 days prior to a 
prolonged intermittent exercise protocol. The protocol was based on the 
Loughborough intermittent shuttle test (LIST) (Nicholas et a l , 2000), but was 
adapted to specifically simulate soccer match play. Subjects’ response to exercise was
assessed by measuring heart rate (HR) throughout exercise, while blood lactate and 
glucose concentrations, and rate of perceived exertion (RPE) were measured prior to 
exercise, at half time, and immediately post-exercise. Moreover, perceived muscle 
soreness and blood concentrations of cortisol, creatine kinase (CK), lipid 
hydroperoxide (HPO), vitamin C, and vitamin E were measured prior to exercise and 
after 20 min, 24 hr, and 48 hr of recovery.
The prolonged intermittent exercise protocol used in this study led to exercise- 
induced stress, as demonstrated by the significant elevation of blood cortisol 
concentrations during exercise (PO.OOl). Moreover, the exercise protocol was 
shown to significantly elevate markers of muscle damage (PO.OOl), delayed onset 
muscle soreness (DOMS) (PO.OOl), and oxidative stress (PO.OOl). These variables 
were affected to an equal extent in placebo and S-PS groups, and had returned to pre­
exercise levels within 48 hours of recovery. However, those supplemented with S-PS 
did demonstrate a trend towards enhanced performance (P=0.082).
It is plausible that the trend of improved performance of the S-PS group, and 
consequent elevation in blood cortisol concentration and oxidative stress markers, 
may have negated any benefits that S-PS supplementation had on these markers. 
Therefore, future research should attempt to clarify the potential ergogenic effect of 
S-PS supplementation, and ascertain if such supplementation has any effect on the 
elevation of blood cortisol and oxidative stress associated with prolonged intermittent 
exercise.
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1 Introduction
Association football (soccer) requires players to work at average exercise intensities 
of approximately 75% of maximum oxygen uptake (%V C >2m ax) (Reilly, 1997). 
However, the intermittent nature of soccer dictates that a player will be required to 
utilise all sources of energy in order to complete the required concentric, eccentric 
and isometric muscular actions (Reilly, 1997; Drust et al., 2000).
The aerobic energy system has been calculated to supply more than 90% of the total 
energy requirements during soccer match play (Bangsbo, 1994a). Reactive Oxygen 
Species (ROS) are produced as by-products in the electron transport chain during 
normal aerobic respiration (Kanter, 1994). These ROS have the capability to cause 
damage to cells by oxidising (removing electrons) components within them. During 
normal resting respiration, the body’s antioxidant defence system can adequately 
quench the ROS. However, during periods where aerobic metabolism is elevated (for 
example during soccer) there is a subsequent increase in ROS production (Kanter, 
1994). Consequently, the antioxidant defences become saturated and an increase in 
oxidative stress ensues (Sen, 1995). In addition, the comparatively low antioxidant 
defences of skeletal muscle (Sen, 1995) make it susceptible to oxidative damage 
(Armstrong et a l , 1991).
The frequent limb accelerations and decelerations during soccer (Reilly and Thomas, 
1976; Reilly, 1997) require extensive eccentric muscular activity. Eccentric activity, 
where the muscle is forcibly extended during activation (Maughan et al., 1989), has
1
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been suggested to cause damage to muscles (Newham et al., 1986) and has been 
consistently associated with muscle soreness (Maughan et al., 1989; Dekkers et al., 
1996; Gulick and Kimura, 1996; Goldfarb, 1999). Consequently, muscle soreness has 
frequently been used as an indirect marker of muscle damage (for example, Fahey 
and Pearl, 1998; Thompson et al., 2001). Armstrong et al. (1991) hypothesised that 
initial muscular damage, as caused by eccentric activity, leads to an influx of calcium 
ions (Ca2+). The resulting loss of Ca2+ homeostasis and the subsequent invasion of 
phagocytic and inflammatory cells are thought to release ROS as by-products 
(Armstrong et al., 1991). Furthermore, markers of oxidative stress have been 
demonstrated to increase during eccentric muscular activity (Alessio et al., 1997) and 
simulated soccer match play (Thompson et al., 2001); consequently, the eccentric 
component of soccer match play provides an additional foundation for muscle 
damage during this type of activity.
Exercise protocols designed to simulate soccer match play have been shown to cause 
increases in blood cortisol concentrations (Thompson et al., 2001), the predominant 
hormone that regulates normal metabolism and the body’s response to stress 
(Monteleone et al., 1990; Monteleone et al., 1992; Kelly, 1999). Cortisol has many 
metabolic functions that include the stimulation of enzymes such as 
phenylethanolamine 7V-methyltransferase (PNMT), which are responsible for the 
conversion of noradrenaline to adrenaline within the adrenal gland (Axelrod and 
Reisine, 1984) and the catabolism of protein through the conversion of protein to 
glucose by gluconeogenesis (Tortora and Anagnostakos, 1987; McArdle et al., 2000). 
The increase in blood cortisol concentration during intermittent exercise results in 
elevated muscle degradation. Furthermore, cortisol exhibits inhibitory effects upon
2
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the inflammatory/immune response (Tsigos and Chrousos, 2002) and consequently 
any muscle degradation occurring during exercise could, in theory, be left untreated.
Phospholipids are the most predominant component in eukaryotic membranes (Stryer, 
1999) and include phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylserine (PS), and phosphatidylinositol (PI) (Vance and Vance, 1996). 
Phosphatidylserine is found almost exclusively within the inner leaflet of a membrane 
and is centrally involved in the maintenance of a cell’s internal environment by 
regulating transport across a membrane (Vance and Vance, 1996). Additionally, PS 
has important roles in signal transduction, secretory vesicle release, cell-to-cell 
communication, and cell growth regulation (Blokland et al., 1999). Until recently, the 
prominent source of PS for supplementation was Bovine Cortex (BC-PS); however, 
the possible transfer of infectious diseases has rendered BC-PS an unsuitable 
supplement. Soybean-derived PS (S-PS) is an alternative source of PS that has been 
suggested to produce comparable results to BC-PS (Fahey and Pearl, 1998; Blokland 
et al., 1999). Furthermore, S-PS has been shown to be a safe nutritional supplement 
(Jorissen et a l , 2002) and is currently commercially available as a memory aid.
Supplementation with BC-PS has been demonstrated to attenuate the loss of neuronal 
function (such as the cognitive decline of the elderly), and subsequently improve 
cognitive functions (for example, Villardita et a l , 1987; Cenacchi et a l , 1993; 
Blokland et a l , 1999). The majority of the available research has focussed on BC-PS 
supplementation in elderly populations (Palmieri et a l, 1987; Villardita et al, 1987; 
Amaducci, 1988; Crook et al, 1992; Cenacchi et a l, 1993); however, more recent
mtroaucuon
research has suggested that the supplementation of younger subjects with S-PS can 
reduce stress and enhance mood following exercise (Benton et a l, 2001).
In addition, PS supplementation has been shown to attenuate the exercise-induced 
release of cortisol and its regulatory hormone, adrenocorticotropin hormone (ACTH) 
(Monteleone et a l, 1990; Monteleone et a l, 1992; Fahey and Pearl, 1998). 
Monteleone and colleagues demonstrated that BC-PS, administered intravenously and 
orally, blunted the cortisol and ACTH response to intermittent cycling (Monteleone et 
al, 1990; Monteleone et a l, 1992). Oral supplementation with S-PS (800 mg-day'1 
PS for 14 days) blunted the release of cortisol and ACTH, enhanced perceived well­
being, and reduced perceived muscle soreness during a 2 week resistance-training 
program (Fahey and Pearl, 1998).
Therefore, it is plausible that the stress reducing effects demonstrated by PS may 
exhibit ergogenic effects on performance during prolonged intermittent activity. 
Furthermore, recent in-vitro investigations have demonstrated a potential antioxidant 
action of PS (Latorraca et a l, 1993; Dacaranhe and Terao, 2001). These findings 
suggest that PS may have the potential to enhance the in-vivo antioxidant defence 
and, therefore, reduce oxidative stress. However, no published data are available to 
evaluate this hypothesis.
As previously described, prolonged intermittent running (using a pattern of running 
designed to simulate soccer match play) has been previously demonstrated to elevate 
markers of physiological stress, muscle damage, muscle soreness, and oxidative 
stress. Therefore, the aim of the current study was to investigate the effects of chronic
i l l ir U U U C llU H
S-PS (750 g-day'1 for 10 days) supplementation on exercise performance and markers 
of exercise stress, muscle damage, and oxidative stress during and following 
prolonged intermittent exercise that was designed to simulated soccer match play.
5
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1.1 Null Hypotheses
HOi Chronic S-PS supplementation will not affect indicators of muscle damage 
following prolonged intermittent exercise.
h o 2 Chronic S-PS supplementation will not affect indicators of oxidative stress 
following prolonged intermittent exercise.
HO3  Chronic S-PS supplementation will not affect the body’s release of cortisol in 
response to prolonged intermittent exercise.
HO4  Chronic S-PS supplementation will not affect the body’s response to 
prolonged intermittent exercise.
6
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2 Review of Literature
2.1 Intermittent Exercise (Soccer)
Soccer is a game of immense worldwide popularity; over 200 million players are 
registered with the game’s governing body, the Federation International de Football 
Association (FIFA, 2003). The financial and commercial opportunities that 
accompany such worldwide popularity and recognition have led to soccer matches 
becoming more frequent, with Manchester United Football Club playing in excess of 
60 matches in the 2002-2003 season (Manchesteronline, 2003). The intense fixture 
schedules, coupled with large financial rewards, means that the players are required to 
produce optimal performances each match, often without sufficient time for the body 
to fully recover from previous matches.
2.1.1 Physiological requirements of soccer
Many studies have investigated the physiological characteristics of soccer players 
(Ekblom, 1986; Tumility, 1993; Bangsbo, 1994a; Reilly, 1997) and the energy 
requirements of soccer matches (Reilly and Thomas, 1976; Bangsbo et a l , 1991; 
Bangsbo, 1994a; Bangsbo, 1994b; Reilly, 1997). Tumility (1993) suggested that 
soccer players exhibit, in general, a good but not outstanding aerobic capacity. 
Moreover, Tumility (1993) suggested that V C^ max values for soccer players average 
60 ml-kg-min'1, which concurs with work by Bangsbo et al (1991). Additionally, the 
average work rate during a soccer match has been estimated to be between 70%
7
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(Bangsbo, 1994a) and 75% (Reilly, 1997) of a player’s V 02max- Consequently, it is 
not surprising that the aerobic energy system is the most prominent source of energy 
in soccer, appearing to account for more than 90% of total energy consumption 
(Bangsbo, 1994a).
However, soccer is an intermittent activity; elite players complete approximately 
1000 discrete bouts of playing activities during a match (Reilly and Thomas, 1976; 
Reilly, 1997). Reilly (1997) stated that whilst the majority of exercise in soccer is at 
submaximal (aerobic) intensity, sprints occur approximately every 90 s, and high- 
intensity effort occurs approximately once every 30 s. Therefore, a player will utilise 
anaerobic energy sources, such as phosphocreatine and anaerobic glycolysis, to 
supply energy for periods of high-intensity, however brief, during soccer match play. 
Furthermore, such repeated acceleration and deceleration may lead to increased 
amounts of eccentric muscular contractions, possibly responsible for the increased 
amount of muscle soreness and damage seen during recovery from simulated soccer 
matches (Thompson et al., 2001; Wadsworth et al., 2004).
Researchers have used physiological measurements to assess the requirements of 
soccer match play, with the most frequently used variables being heart rate (HR) and 
blood lactate concentrations. Reilly (1997) stated an average HR during soccer match 
play of around 165 beats-min'1, and Ekblom (1986) found a range of 160 -  180 
beats-min'1. Bangsbo (1994a) recognised that oxygen uptake (V  O2) can be directly
measured during soccer-related activities; however to directly measure. V O2 during a 
soccer match would interfere with normal play (Drust et al., 2000). Subsequently, 
researchers have used the relationship between HR and V O2 to infer the level at
8
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which a player is working during a soccer match. Such estimations have led to a 
relative exercise intensity of approximately 75% V C^ max during soccer match play 
(Ekblom, 1986; Bangsbo, 1994b; Reilly, 1997).
Blood lactate concentration can provide an indication of the amount of anaerobic 
work that a player performs during a soccer match (Bangsbo, 1994a), although the 
duration of high-intensity exercise in soccer may be too short to provide a significant 
increase in blood lactate (Bangsbo, 1994a). Reilly (1997) acknowledged that blood 
lactate concentrations are not “generally” high, while Ekblom (1986) stated a range of
6 - 1 0  mmolT1 for Swedish league players, similar to a range of 7 -  8 mmolT1 seen 
in German league players (Gerisch et a l , 1988). However, work on Danish league 
players by Bangsbo et al (1991) found an average blood lactate concentration of 4.4 
mmolT1, and a range of only 2.1 -  6.9 mmoH'1. Moreover, blood lactate 
concentrations tend to be higher at more intense levels of competition. Ekblom (1986)
demonstrated blood lactate levels of Swedish 1st division players to be 9.5 and 7.5
1mmol-r (for the first and second half respectively), and Swedish 4 division players 
to be 4.0 and 3.9 mmolT1. Furthermore, Ekblom (1986) showed 2nd and 3rd division 
players to exhibit blood lactate concentrations between these groups. Reilly (1997) 
concluded that the overall anaerobic energy yield during a game is likely to be low 
and notational analysis work suggests that high-intensity work consists of 8% of total 
playing time (Bangsbo et a l , 1991).
9
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2.1.2 Notational analysis & soccer
Notational analysis studies of soccer matches have used various aspects of the game 
to quantify a player’s work rate. Reilly and Thomas (1976) analysed the distance 
covered during soccer match play, known as time-distance work. Alternatively, 
Bangsbo et al (1991) investigated the amount of time spent on different activities, 
which has been referred to as time-motion analysis. At present, the general consensus 
within notational analysis is that outfield players cover 8-12 km during a match 
(Reilly, 1997); however, the distance covered depends upon numerous factors, such 
as playing position, opposition ability, and team tactics/style of play. The ever- 
changing tactics and styles of play favoured by coaches, coupled with the contrasting 
styles of play of different countries and even continents, make it impossible to 
quantify a solitary value as the average distance covered during a soccer match.
While the distance covered during a match may vary, the amount of high-intensity 
exercise appears to be more constant (Bangsbo, 1994b). Early work on English 
League players by Reilly and Thomas (1976) found that, on average, the overall 
distance covered by outfield players during a match was approximately 10 km, which 
concurs with more recent work by Reilly (1997). The distance covered in the work of 
Reilly and Thomas (1976) consisted of 25% walking, 37% jogging, 20% cruising 
sub-maximally, 11% sprinting and 7% moving backwards. Conducted almost 30 
years ago, the work of Reilly and Thomas (1976) is dated, and as such does not, and 
cannot, reflect the changing styles of soccer match play during the time since its 
publication. However, this data provides a good example of the activity patterns of 
English League players, and remains a ‘standard’ against which other .researchers can
10
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compare not only their results but also their procedures (Hughes and Franks, 1997). 
Subsequently, despite its age, the time-distance work of Reilly and Thomas (1976) 
should be considered when looking at intermittent exercise.
Time-motion analysis by Bangsbo et al (1991) on Danish League players 
concentrated on the percentage of total playing time spent on each activity. Bangsbo 
et al. (1991) found that total playing time consisted of 17.1% standing still, 40.4% 
walking, 35.1% low intensity running (consisting of 16.7% jogging, 17.1% low-speed 
running and 1.3% backwards running) and 8.1% high intensity running (consisting of 
5.3% moderate-speed running, 2.1% high-speed running and 0.7% sprint running). 
This concurred with the work of Reilly and Thomas (1976) on English league 
players, as it recognised a significantly greater proportion of time spent on walking 
and low-intensity running.
Notational work on soccer focuses on categorising a player’s movements with regards 
to walking, jogging, cruising and sprinting, however it should be acknowledged that 
hidden within these categories are sideways and diagonal movements, as well as 
skills within the game (such as jumping to win possession of the ball); all of which 
have energy consuming consequences (Reilly, 1997). Running backwards and 
sideways lead to elevated energy expenditures in comparison with normal running at 
the same speeds (Reilly, 1997) and as such should be considered when analysing 
soccer. Reilly (1997) stated that the added cost of dribbling a ball is 5.2 kJ-min'1, 
however very little distance is actually covered in possession of the ball, leading 
Reilly (1997) to acknowledge that the majority of activity in soccer match play occurs 
in the periphery, in the guise of off-the-ball positional movements. Most importantly,
11
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running backwards and sideways leads to increased eccentric muscular activity in 
numerous different muscle groups, which can in turn lead to elevated soreness and/or 
damage following exercise.
2.1.3 Simulation of a soccer match
The development of an exercise protocol that accurately simulates the activity 
patterns and physiological demands of a soccer match is an increasingly prominent 
area of research (Drust et a l , 2000; Nicholas et a l , 2000; Wadsworth et a l , 2004). 
However, the simulation of soccer match play remains a relatively new research area, 
and protocols are therefore not without fault. The random movement patterns during 
soccer, with the game encompassing in excess of 1000 changes in speed in 90 min of 
play (Reilly, 1997), makes it difficult for researchers to accurately simulate soccer 
match play in a controlled environment. Field-based protocols (Nicholas et a l, 2000; 
Wadsworth et al, 2004) and laboratory-based protocols (Drust et al, 2000) do not 
replicate the game fully, as researchers aim for structure, control and replication 
within the exercise protocols. The need for structure and control within an exercise 
protocol can lead to a pay-off in replication, for example neglecting movements such 
as games skills (e.g. kicking, heading, tackling).
Drust et al (2000) developed a laboratory-based protocol using a motorised treadmill 
that was designed to represent the work rates observed during soccer match play. The 
protocol consisted of walking (6 knrhr'1), jogging (12 knrhr'1), cruising (15 knrhr'1) 
and sprinting (21 knrhr'1) for two 22.5-min cycles. Each 22.5-min cycle consisted of 
23 discrete bouts of activity: six bouts of walking, six bouts of jogging, three cruises
12
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and eight sprints, arranged in a non-cyclical manner. As the subjects used were 
university standard soccer players, they can be considered as well familiarised 
subjects, and such their responses to the protocol can be considered ‘normal’, with 
regards to their usual soccer match play, and not ‘one-off responses. The exercise 
protocol worked players at an average of 68% V C^ max, similar to the 70% V Q?max 
stated for soccer match play by Bangsbo (1994a), but was slightly lower than the 75% 
V 02max frequently stated with reference to soccer (Ekblom, 1986; Bangsbo, 1994b; 
Reilly, 1997). Mean blood lactate concentration of 7.7 ± 0.6 mmolT1 fell within the 
range of 6 -  10 mmolT1 found by Ekblom (1986) and the range of 7 -  8 mmolT1 
suggested by Gerisch et al (1988). However, Bangsbo et al (1991) observed a 
significantly lower mean blood lactate concentration of 4.4 mmolT1 (range 2.1-6.9 
mmolT1). The average HR recorded for the protocol of 168 ± 10 beats-min*1 
concurred with the average value of 165 beats-min*1 stated by Reilly (1997), and fell 
within the range of 160 -  180 beats-min*1 seen during a soccer match by Ekblom 
(1986). However, the duration (45 min) is only half that of a soccer match 
(acknowledged by the researchers), and subsequently the physiological demands of a 
soccer match were not successfully replicated. The duration of the protocol, coupled 
with the activity being performed on a treadmill, is potentially detrimental to the 
environmental validity of the protocol, which is concerned with the sum of external 
influences affecting an individual (Cassell, 1995). With regard to soccer simulation, 
environmental validity is concerned with how well the whole situation has been 
replicated, and how realistic the simulation feels to those completing it. Subsequently, 
it is possible that this laboratory-based protocol sacrifices the degree to which soccer 
is replicated in favour of structure and control.
13
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The Loughborough Intermittent Shuttle Test (LIST) (Nicholas et al., 2000) is a 
controlled field test designed to simulate the activity patterns typically seen in soccer 
match play. The LIST consists of two parts: Part A consisting of 5 x 15-min periods 
of variable-intensity shuttle running over 20 m, each separated by a 3 min rest period; 
Part B consisting of continuous running, alternating every 20m between 55% and 
95% V Chmax until volitional exhaustion. Average total distance covered was 12.4 km, 
similar to an average distance of 12 km stated by Reilly (1997). The average total 
distance was, however, notably higher than the average values recorded for a soccer 
match of 10.8 km (Bangsbo et al, 1991) and 10 km (Tumility, 1993). Reilly and 
Thomas (1976) showed distance covered during a soccer match to vary with position, 
with values ranging from 8 - 1 3  km, and Reilly (1997) stated that outfield players 
cover 8-12 km during a match. Nicholas et al (2000) used well-familiarised subjects 
(University soccer and rugby players) and consequently the exercise protocol can be 
said to cause ‘normal’ responses for intermittent exercise. Blood lactate concentration 
during the LIST reached 7 ± 1.0 mmolT1 in the 1st 15 min, and maintained this level 
throughout the test. This blood lactate concentration was similar to those seen during 
a soccer match (Ekblom, 1986; Gerisch et a l, 1988) and below the limit for soccer 
players of 10 mmol-I'1 suggested by Reilly (1997). The blood lactate concentrations 
observed during the LIST were, however, significantly higher than the average value 
of 4.4 mmolT1 (range 2.1-6.9 mmolT1) reported by Bangsbo et al (1991). Heart rate 
(HR) during the LIST was shown to vary between 166 -  176 beats-min'1, similar to 
the range of 160 -  180 beats-min'1 seen during a soccer match by Ekblom (1986) and 
the average value of around 165 beats-min'1 stated by Reilly (1997).
14
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The LIST failed to include a 15-min half-time break, which could decrease the 
validity of the test with respect to accurate simulation of a soccer match. The half- 
time break not only allows teams and management a chance to address any tactical 
shortcomings observed but also presents players with an opportunity to physically 
and mentally recover. The LIST provides individuals with just a 3-min recovery 
break after 45 min (half-time), and in doing so denies them the chance to physically 
recover as they would do in a soccer match, where a 15-min half-time is stated within 
the rules of the game (FIFA, 2002). During a 15-min half-time recovery period, HR 
has been shown to return towards baseline values (Wadsworth et a l , 2004). 
Furthermore, the lack of a 15-min half-time has possible negative effects on how 
realistic the simulation feels to those completing it (the environmental validity).
Wadsworth et al (2004) used a modified version of the LIST protocol (Nicholas et 
a l , 2000) that included sideways running (in the form of a zigzag) and backwards 
jogging in order to simulate the eccentric component of soccer. The protocol 
consisted of two parts: Part A consisting of 5 x 15-min periods of variable-intensity 
shuttle running over 20 m, each separated by a 3 min rest period; Part B consisting of 
a multi-stage fitness test. Furthermore, this protocol included a 15-min ‘half-time’ 
recovery period following 45 min of the protocol, to allow subjects similar recovery 
time to that of a soccer match, and further simulate the routine of a soccer match. This 
study used well-familiarised university standard soccer players and consequently the 
exercise protocol can be said to cause ‘normal’ responses for intermittent exercise. 
Mean exercising HR was 152 ± 3 beatsmin'1, slightly lower than the range of 160 -  
180 beats min'1 seen during a soccer match by Ekblom (1986) and the average value 
of around 165 beatsmin'1 stated by Reilly (1997). Average peak blood lactate
15
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concentrations (for all trials) were 5.13 ± 0.33 mmolT1, slightly below those seen 
during a soccer match (Ekblom, 1986; Gerisch et a l , 1988), and below the limit for 
soccer players of 10 mmol I'1 suggested by Reilly (1997). The blood lactate 
concentrations observed were, however, higher than the average value of 4.4 mmolT1 
(range 2.1 - 6.9 mmol I*1) reported by Bangsbo et al (1991). In addition, Wadsworth 
et al (2004) analysed recovery following exercise, and found the protocol to cause 
elevated muscle soreness 24 hours post-exercise, and adversely affect sprint 
performance for 2 days after exercise.
None of these protocols (Drust et a l , 2000; Nicholas et a l , 2000; Wadsworth et a l , 
2004) included games skills (e.g. kicking, heading, tackling). This has potential 
detrimental consequences with regards to environmental validity and replication of 
the energy demands of soccer match play. However, it is likely that the detrimental 
effects upon energy demand are negligible, as Reilly (1997) stated that the majority 
of activity is performed off-the-ball, with the proportion of total distance covered in 
possession of the ball known to be low, varying between 0.25 and 0.4% (Reilly, 
1990). Furthermore, the inclusion of such games skills could make it more difficult to 
assess the physiological responses during soccer specific exercise under controlled 
conditions (Drust et a l , 2000).
The lack of sideways and backwards movement in both Drust et al (2000) and 
Nicholas et al (2000) protocols may be much more problematic, limiting how 
effectively soccer match play is simulated by each protocol, as 16% of the total 
distance covered during a soccer match is sideways or backwards movement (Reilly,
1990). By leaving such movements out of their respective exercise protocols, Drust et
16
al (2000) and Nicholas et al. (2000) can be said to under-replicate the eccentric 
component of soccer match play, which is thought to lead to the elevated muscle 
soreness and adverse performance seen following exercise, such as that exhibited in 
the 2 days following exercise by Wadsworth et al (2004). Additionally, the exclusion 
of such movements could compromise the environmental validity of such protocols.
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2.2 Acute Responses to Intermittent Exercise
2.2.1 Glucocorticoid responses
Glucocorticoids are a group of hormones that are concerned with normal metabolism 
and the body’s resistance to stress (Tortora and Anagnostakos, 1987; Tsigos and 
Chrousos, 2002). Cortisol is the most abundant glucocorticoid, and is responsible for 
approximately 95% of all glucocorticoids’ activity (Tortora and Anagnostakos, 1987; 
McArdle et al., 2000; Tsigos and Chrousos, 2002). Exercise stress has been shown to 
exert a disruptive influence on normal circadian release of cortisol (Kelly, 1999), 
while blood cortisol levels have been shown to continually increase until the end of 
simulated soccer match play, in the form of the LIST (Thompson et al., 2001).
Glucocorticoids participate in the control of whole body homeostasis and regulate the 
response to exercise stress (Tsigos and Chrousos, 2002), as well as controlling 
changes in enzymatic activity (Axelrod and Reisine, 1984). Glucocorticoids are 
catabolic hormones, and during exercise they stimulate protein breakdown 
(catabolism) to amino acids in all cells except the liver (Kelly, 1999). In the liver, the 
amino acids may be synthesised into enzymes required for metabolic reactions, such 
as catecholamine biosynthetic enzymes like phenylethanolamine TV-methyltransferase 
(PNMT), responsible for the conversion of noradrenaline to adrenaline within the 
adrenal gland (Axelrod and Reisine, 1984). Alternatively, the amino acids may be 
converted to glucose, in a process called gluconeogenesis (Tortora and Anagnostakos, 
1987; Kelly, 1999; McArdle et a l , 2000), in order to meet the additional metabolic 
requirements of exercise. Furthermore, glucocorticoids can stimulate the release of
18
ivcvicw  u i JL/iLcra.Lurc
fatty acids from adipose tissue (McArdle et a l , 2000), again to meet the additional 
metabolic requirements of exercise, as well as supporting the gluconeogenic action of 
hormones such as glucagon and human growth hormone (Kelly, 1999).
The catabolic nature of glucocorticoids means that high concentrations can lead to 
large amounts of muscle degradation during prolonged exercise, as the need for 
alternative energy sources increases (Hoffman et al., 1997; Tsigos and Chrousos, 
2002). Furthermore, cortisol has inhibitory effects upon virtually all components of 
the inflammatory/immune response (Tsigos and Chrousos, 2002). Consequently, any 
muscle degradation occurring during exercise would, in theory, be left untreated. 
Subsequently, cortisol levels elevated by exercise may result in muscle degradation or 
damage, which could inhibit a player’s performance during a soccer match, and their 
recovery following match play. The inhibitory effects of cortisol upon the 
inflammatory/immune response could have far-reaching effects with regards to the 
elevated production of other potentially damaging reactive oxygen species (ROS), 
substances that have the potential to damage membranes and other cell components 
(Hancock, 1999; Urso and Clarkson, 2003). Additionally, cortisol is said to exhibit 
antireproductive and antigrowth effects (Tsigos and Chrousos, 2002), and as such 
elevated levels could have negative effects on a player’s hormonal balance 
(homeostasis), and antigrowth effects may inhibit a player’s physiological 
development and recovery from muscle damage.
A variety of stressful events (for example, fright, exercise, temperature extremities, 
disease, and mental stress) can cause elevated levels of cortisol (Kelly, 1999). 
However, cortisol response to physical activity can vary depending upon exercise
19
r e v ie w  01  JLiieramre
intensity, duration, participant fitness level and nutritional status (McArdle et al.,
2000). Moreover, cortisol output increases directly in relation to exercise intensity 
(Kelly, 1999). Monteleone et al (1990) showed that cortisol levels increased in 8 
familiarised young males during 20 min of intermittent cycling at increasing 
intensities, and a similar increase was demonstrated in 9 familiarised young males 
during intermittent cycling of the same protocol (Monteleone et a l , 1992). However, 
2 weeks of resistive exercise-induced overtraining did not significantly elevate 
cortisol levels in 11 trained young males (Fahey and Pearl, 1998). In addition, blood 
cortisol levels of young male subjects have been shown to continually increase until 
the end of simulated soccer match play, in the form of the LIST (Thompson et a l ,
2001).
Exercise induced-stress leads to the activation of the hypothalamo-pituitary-adrenal 
(HPA) axis, which results in elevated levels of cortisol (Axelrod and Reisine, 1984). 
Exercise induced-stress leads to the hypothalamic secretion of corticotropin-releasing 
factor (CRF); although, the mechanisms via which stress does this remain unclear 
(Tsigos and Chrousos, 2002). Corticotropin-releasing factor synthesized by the 
hypothalamus reaches the pituitary gland by a ‘private’ portal blood supply, where it 
stimulates the release of adrenocorticotropic hormone (ACTH) (Axelrod and Reisine, 
1984; Tsigos and Chrousos, 2002). This ACTH is then transported in the blood to the 
adrenal cortex, where the increased concentrations of ACTH subsequently initiate the 
synthesis and release of cortisol, which consequently initiates its stress-reducing 
responses (Axelrod and Reisine, 1984; Tsigos and Chrousos, 2002).
20
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Concentrations of ACTH increase with exercise duration if intensity exceeds 25% of 
V 02max (McArdle et a l, 2000); however, the release of ACTH is not solely 
dependant upon CRF (Tsigos and Chrousos, 2002). Multiple factors including CRF, 
arginine-vasopressin (AVP), catecholamines and possibly other hormones (Axelrod 
and Reisine, 1984) stimulate the release of ACTH, either individually or interacting 
in order to achieve optimal results. Tsigos and Chrousos (2002) hypothesised that 
CRF and AVP have a ‘reciprocal positive interaction,’ with each neuropeptide 
stimulating secretion of the other. During acute stress, the amplitude and 
synchronisation of the CRF and AVP pulsations (in the hypophyseal portal system) 
increases, resulting in increases of ACTH and cortisol secretory episodes (Tsigos and 
Chrousos, 2002).
Glucocorticoids not only participate in the control of whole body homeostasis, but 
also play a key role in the termination of the stress response, by inhibiting the 
secretion of ACTH (Tsigos and Chrousos, 2002). Glucocorticoids regulate 
catecholamine biosynthesis (in the adrenal medulla) by releasing amino acids that can 
then be converted by the liver into catecholamine biosynthetic enzymes such as 
PNMT, responsible for the conversion of noradrenaline to adrenaline within the 
adrenal gland (Axelrod and Reisine, 1984). These catecholamines are involved in 
ACTH regulation, as they stimulate ACTH release (Axelrod and Reisine, 1984). As 
such, glucocorticoids such as cortisol can inhibit catecholamine synthesis, and 
subsequently ACTH release (Axelrod and Reisine, 1984); consequently, the HPA 
axis can be said to have at least some degree of negative feedback control.
21
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The inhibitory glucocorticoid feedback on ACTH acts to limit the duration of total 
tissue exposure to glucocorticoids. Tsigos and Chrousos (2002) suggest that the acute 
nature of the HPA axis response to exercise renders its antireproductive, antigrowth, 
catabolic and immunosuppressive effects temporarily beneficial rather than 
damaging; however, the immunosuppressive effects of cortisol suggest that any 
muscle degradation occurring during exercise could be left untreated. This could lead 
to elevated production of ROS, which may lead to cell membranes being attacked 
(oxidised), and subsequent muscle damage. This could be inhibitory to a player’s 
performance during a soccer match, and may have negative effects on their recovery 
post exercise.
2.2.2 Acute heart rate response to exercise
Cardiac output increases in direct proportion to exercise intensity (McArdle et a l , 
2000), in order to fulfil the aerobic energy requirements of active muscle. To increase 
cardiac output, the amount of blood ejected with each stroke (stroke volume) and the 
rate of pumping (heart rate, HR) can both be increased. McArdle et al (2000) stated 
that a linear relationship exists between HR and oxygen uptake (during increasing 
intensity exercise) for both endurance athletes & sedentary college students, thus 
suggesting that such a relationship occurs for most, if not all, individuals. Tsigos and 
Chrousos (2002) stated that cardiac output is accelerated during stress, and 
subsequently blood flow is redirected to provide the brain, heart and muscles with 
fuel. Consequently, an increase in HR is one of the most frequently measured 
responses to exercise stress.
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This increase in HR could be regulated by the HPA axis, as amino acids from 
proteins broken-down by cortisol may be converted into catecholamine biosynthetic 
enzymes in the liver. The most important of these with regards to HR is PNMT, 
which is responsible for the conversion of noradrenaline to adrenaline within the 
adrenal gland (Axelrod and Reisine, 1984), and as such PNMT regulates the 
concentrations of adrenaline and noradrenaline. As part of the sympathetic HR 
control system, elevated levels of adrenaline and noradrenaline cause increased 
myocardial contractility and accelerate sinoatrial (S-A) node depolarisation, which 
increases HR (McArdle et a l , 2000). Accordingly, an increased level of cortisol, and 
in turn PNMT and catecholamines, contributes to the increase in HR seen during 
exercise (Axelrod and Reisine, 1984). Reducing the effect of the sympathetic control 
system, by suppressing cortisol levels, and in turn PNMT activity, is a method by 
which HR can be lowered (Tsigos and Chrousos, 2002). However, catecholamines 
are fast acting hormones, whilst the cortisol response is characterised by a slower 
increase following the onset of exercise (Tsigos and Chorus, 2002); consequently the 
benefits of regulating HR in this manner would be limited to the latter stages of 
exercise, and recovery following exercise.
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2.3 Intermittent Exercise and Muscle Damage
2.3.1 Muscle Damage
Eccentric muscular activity, where the muscle is forcibly extended during activation 
(Maughan et a l, 1989), has been suggested to cause damage to muscles (Newham et 
al, 1986). This damage to muscles is thought to lead to the pain, discomfort and loss 
of function often experienced after exercise (Newham et al, 1986). Soccer is an 
intermittent activity, encompassing many discrete bouts of playing activities during a 
match that involve changing speeds, which requires considerable eccentric muscular 
activity. Consequently, soccer players are at risk of muscle damage during a game, 
and simulated soccer match play has been shown to elevate post-exercise markers of 
muscle damage (for example, Thompson et a l, 2001; Wadsworth et al, 2004).
There are four main theories behind the mechanisms of initial muscle damage: (1) 
tom tissue theory, (2) connective tissue theory, (3) enzyme efflux theory and (4) 
tissue fluid theory (Gulick and Kimura, 1996). The tom tissue theory suggests that 
damage occurs at the z-lines, the ‘weak link’ of the contractile component of muscle 
(Friden, 1984; Newham et a l, 1986). The connective tissue theory focuses on the 
muscle-tendon junction, as the orientation of the muscle fibres at this point makes 
these fibres more susceptible to trauma when stretched, as in eccentric activity 
(Newham et a l, 1986). Such muscle trauma disrupts the permeability barrier 
provided by the sarcolemma, therefore permitting the abnormal diffusion of 
molecules (for example, calcium ions, Ca2+, and creatine kinase) into or out of the 
muscle (Armstrong et al, 1991). The enzyme efflux theory suggests that collagen and
24
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protein metabolites, such as creatine phosphokinase, may be released into the 
extracellular spaces, with the intensity and duration of eccentric activity influencing 
membrane permeability, and fibre damage. Calcium ions are thought to be released, 
and subsequently damage the muscle when in direct contact (Gulick and Kimura, 
1996). The tissue fluid theory suggests that the accumulation of histamine, kinins and 
potassium in the interstitial space (between cells and tissue) could disrupt diffusion 
gradients, thus potentially causing damage, and swelling (oedema) (Gulick and 
Kimura, 1996).
2.3.2 Oxidative Stress
Oxidative stress refers to an imbalance in the pro- and antioxidant status in favour of 
the former (Sen, 1995; Urso and Clarkson, 2003). Pro-oxidants are substances that 
can oxidise (removal of electron(s) from) a substrate. Antioxidants can be defined as 
any substance that, when present in lower concentrations than the oxidizable 
substrate, significantly delays or prevents oxidation of the substrate (Sen, 1995). Free 
radicals are defined as molecules with an unpaired electron in their outer orbital 
(Kanter, 1994) and, as such, are pro-oxidants. The term reactive oxygen species 
(ROS) is the collective term for oxygen-based free radicals, such as the hydroxyl 
radical (OH-), and other oxygen derivatives with free radical properties, such as 
superoxide (02’’) and hydrogen peroxide (H2O2). All ROS have free radical 
properties, or serve as precursors for more potent free radicals (Kanter, 1994), and 
consequently have the capability damage to cells by oxidising components within 
them. Particularly susceptable are cell membranes (Hancock, 1999), proteins
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(enzymes) (Latorraca et a l , 1993) and also deoxyribonucleic acid (DNA) (Sen, 
1995).
Hydroxyl and O2 ' radicals have the potential to immediately damage whatever they 
contact (Hancock, 1999). Multiple unsaturation points in polyunsaturated fatty acids 
(PUFA) make them, and the membranes that they form, highly susceptible to ROS 
attack and oxidative damage (Sen, 1995). Physical training and acute bouts of 
exercise are known to decrease phospholipid and PUFA levels in human erythrocyte 
membranes, and it is likely that this response is due to the lipid peroxidation of the 
membranes (Sumikawa et a l , 1993). Membrane lipid peroxidation occurs when a 
ROS attacks the lipid membrane of a cell. The by-products of this reaction can be 
more ROS; H2O2 , for example, is a by-product of C^'- oxidising a lipid (Hancock, 
1999). In addition, the oxidised lipid then reacts with O2 to form a lipid peroxy 
radical, which can react with more lipid molecules, thus propagating a chain reaction 
that can seriously damage cell membranes and other cell components (Hancock, 
1999; Urso and Clarkson, 2003). Lipid hydroperoxide (HPO) is a by-product that is 
often used as a marker of lipid peroxidation (Urso and Clarkson, 2003).
Armstrong et al (1991) proposed a sequence of damage to recovery hypothesis, 
suggesting that initial muscular damage disrupts the permeability barrier provided by 
the sarcolemma, thus permitting abnormal diffusion of molecules (for example, Ca , 
and intramuscular enzymes) down their respective concentration gradients into or out
1
of the cell. The loss of Ca homeostasis is prominent, as elevated concentrations of
• O j .intracellular Ca activate numerous proteolytic and phospholipolytic pathways, 
which degrade structural and contractile proteins and membrane phospholipids
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respectively, and subsequently cause further muscle damage. Increased intracellular
9+Ca levels inhibit creatine kinase (CK) activity (Armstrong et a l, 1991), causing a 
subsequent rise in extracellular CK; this elevation is associated with, and used as an 
indirect indicator of, cell membrane damage in muscle (for example, Child et al, 
1999; Thompson et al, 2001). Elevated CK activities have been demonstrated 
following prolonged simulated soccer match play, peaking 24 hours post-exercise in 
9 habitually active, familiarised young males (Thompson et al, 2001). Thompson et 
al (2001) concluded that the simulated soccer protocol increased free-radical 
production to the extent that antioxidant defences were overwhelmed and damage 
occurred.
Furthermore, intermittent exercise, such as soccer, elicits a unique HR response, as 
periods of activity are coupled with periods of inactivity, or recovery periods. 
Additionally, periods of high-intensity work are often followed by periods of low- 
intensity work. Consequently, not only does an individual’s HR have numerous 
opportunities to recover (slow-down) but also the constant rise and fall of HR leads to 
frequent perfusion and reperfusion of muscle cells in particular, and subsequently an 
inconstant oxygen flux. The inconstant oxygen flux may cause the production of free 
radicals and ROS (Armstrong et a l, 1991), and it could lead to damage to red blood 
cells, thus releasing the highly reactive free iron ions (FE and FE ) which in turn 
can lead to more ROS production (Armstrong et a l, 1991). Consequently, athletes 
participating in intermittent exercise could be at risk of damage by ROS, known as 
oxidative stress (Sen, 1995; Urso and Clarkson, 2003).
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2.3.3 Antioxidant defence
It is not only a necessity to stop ROS from engaging in uncontrolled reactions; it is 
considered a prerequisite for cell survival (Karlsson, 1997). The antioxidant defence 
system of the body comprisies primarily of scavenger enzymes and carbon-ring 
(phenol) based compounds such as vitamins A, E, K, beta-carotene and quinol. There 
are three major antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT) 
and glutathione peroxidase (GP). These defend against oxidative stress by reducing 
the ROS (by donating electrons), and as such are most prevelant in tissues with high 
oxygen consumption, such as the liver brain and heart (Kanter, 1994). Consequently, 
antioxidant enzyme concentrations are lower in skeletal muscle, thus making defence 
systems here more susceptible to be overwhelmed during exercise, and subsequent 
muscle damage (Kanter, 1994). Phenol-based compounds act in much the same 
manner, quenching ROS by releasing electrons from the phenol ring, which reduce 
the ROS. Some antioxidant vitamins (for example, vitamins C and E) have been 
shown to act together in the form of an antioxidant chain reaction (Goldfarb, 1999).
Despite the ‘sequence of damage to recovery’ theory for ROS production (Armstrong 
et al., 1991), the most significant pathway for the production of free radicals (and 
ROS) within living systems is the one-electron reduction of molecular oxygen (O2) 
that occurs in the mitochondrial electron transport system during respiration (Kanter, 
1994). When aerobic animals respire, oxygen is reduced to form water (H2 O); during 
this process adenosine triphosphate (ATP) is produced. Four electrons need to be 
added to O2 in order to produce H2O, but O2 can only physically receive one electron
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at a time. This univalent pathway of O2 reduction (Kanter, 1994) subsequently leads 
to the production of ROS.
Under normal respiration, the body’s antioxidants can detoxify the ROS created, and 
thus avoid/limit cellular damage. During exercise, however, there is an elevated 
metabolism, in order to meet elevated energy requirements, and a subsequent 
increased production of ROS. In addition, skeletal muscle is highly susceptible to 
oxidative stress, and subsequent damage, during exercise (Sen, 1995). Simulated 
soccer match play, in the form of the LIST, has been shown to increase markers of 
lipid peroxidation in 9 habitually active, familiarised, young males to the extent that 
antioxidant defences were overwhelmed (Thompson et a l, 2001).
In spite of the defence systems of the body, it has frequently been estimated that 
between 5 and 6% of the total electron flux Teaks off to generate ROS (Kanter, 
1994; Hancock, 1999). Soccer players consistently work on average at 70% of their 
V 02max> and this means that mitochondrial respiration is elevated, to match ATP 
synthesis to ATP hydrolysis, thus producing more ROS (Armstrong et al, 1991), and 
hence leading to saturation of the body’s defence system. Trained soccer players have 
demonstrated enhanced antioxidant defences (Brites et a l, 1999), yet despite this 
simulated soccer match play has been shown to elicit oxidative stress (Thompson et 
al, 2001), suggesting that their enhanced defence is still inadequate during soccer 
match play.
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2.3.4 Delayed Onset Muscle Soreness (DOMS)
Eccentric muscle activity has been consistently shown to cause the greatest post­
exercise muscle soreness (Maughan et a l , 1989; Dekkers et a l , 1996; Gulick and 
Kimura, 1996; Goldfarb, 1999), a condition known as delayed onset muscle soreness 
(DOMS). Delayed onset muscle soreness has been shown to peak between 24 and 48 
hours after eccentric exercise (Maughan et al., 1989; Gulick and Kimura, 1996) and 
cease after 5 - 7  days. Intermittent exercise, such as soccer, requires extensive 
eccentric muscular activity during limb acceleration and deceleration, and soccer has 
been shown to include up to 1000 changes of activity/speed in a game (Reilly, 1990); 
as such, soccer players could be at risk of generating DOMS. Furthermore, 
Wadsworth et al (2004) demonstrated simulated soccer match play to elevate 
DOMS, measured by perceived muscle soreness, above pre-exercise levels 24 & 48 
hours post-exercise in 8 habitually active, familiarised, young males, with levels 
returning to pre-exercise values after 72 hours.
Delayed onset muscle soreness has been suggested to consist of two phases: (1) 
muscle destruction caused by excessive force, and (2) secondary cellular damage in 
response to Ca overload induced by tissue trauma (Armstrong et a l , 1991; Gulick 
and Kimura, 1996). Consequently, increased intracellular Ca levels, caused by the 
sequence of damage to recovery hypothesis proposed by Armstrong et al (1991), not 
only inhibits the activity of intracellular enzymes such as CK but may also be at least 
partly responsible for the soreness exhibited in young males following prolonged 
intermittent exercise (Thompson et a l , 2001; Wadsworth et a l , 2004). Perceived 
muscle soreness remains the most readily available and accessible method of
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assessing DOMS, and has been used to demonstrate DOMS following prolonged 
intermittent exercise (Thompson et a l, 1999; Thompson et al., 2001; Wadsworth et 
al, 2004). Furthermore, DOMS has been suggested to be a ‘manifestation of muscle 
damage’ (Urso and Clarkson, 2003); consequently, perceived soreness is often 
measured in addition to enzymatic markers of muscle damage such as CK (Thompson 
et al, 1999; Thompson et a l, 2001).
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Phosphatidylserine (PS) is a glycerol-based phospholipid (a phosphoglyceride), 
consisting of a glycerol backbone, two fatty acid chains and a phosphorylated alcohol 
head group (Figure 1), which in the case of PS is serine. Identified more than 60 years 
ago by Folch and Schneider (Pepeu et a l , 1996), PS is an acidic phospholipid found, 
in small amounts, in animals, higher plants and micro-organisms (Pepeu et al, 1996). 
Moreover, PS appears to be essential to the functioning of all mammalian cells 
(Blokland et al, 1999).
Phosphatidylserine (PS) can be obtained from many sources, and until very recently 
the predominant source of PS was Bovine Cortex (BC-PS). Studies conducted as 
recently as 1992 (Monteleone et a l, 1992) supplemented with BC-PS; however, the 
possible transfer of infectious diseases (such as Bovine Spongiform Encephalopathy, 
BSE, and Creutzfeld-Jakob Disease, CJD) has rendered BC-PS as an unsuitable 
supplement, especially in humans. Another constraint of BC-PS is that the yield of PS 
from BC is low (Blokland et al, 1999), although this is of secondary importance to 
the potential infection of humans. Alternative sources of PS are Soybean-derived PS 
(S-PS) and Egg-derived PS (E-PS), but these are not identical in structure to BC-PS 
(Blokland et al, 1999). Phosphatidylserine from these alternative sources has a 
similar molecular make-up with regards to glycerol moiety and serine head group, but 
fatty acid composition is different. Soybean-derived PS (S-PS) is virtually devoid of 
arachidonic and docosa hexenoic acids, whilst BC-PS and E-PS are similarly rich in 
these fatty acids (Blokland et al, 1999). Despite the different molecular make-up of 
BC-PS and S-PS, studies have found that supplementing with S-PS produces similar
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results as BC-PS with regards to both cognition (Blokland et al., 1999) and recovery 
after exercise stress (Fahey and Pearl, 1998). Moreover, S-PS has been shown to be a 
safe nutritional supplement (Jorissen et al., 2002) with a bioavailability that is similar 
to BC-PS (Blokland et al., 1999).
2.4.1 Phosphatidylserine and cognitive function
Phosphatidylserine is a constituent of the membranes in neurones, and has important 
roles in their function. Furthermore, PS is involved in the maintenance of a cell’s 
internal environment (by regulating transport across a membrane), signal 
transduction, secretory vesicle release, cell-to-cell communication, and cell growth 
regulation (Blokland et al., 1999). Consequently, supplementation with PS is thought 
to attenuate the loss of neuronal function (such as the cognitive decline of the 
elderly), and as such improve cognitive functions (Pepeu et al., 1996; Blokland et a l , 
1999). Numerous studies have investigated the potential cognitive and behavioural 
benefits of PS; Table 1 summarises the findings of investigations that have used 
placebo-controlled, double-blind study designs.
Research by Amaducci et al (1988), in which 142 subjects between 40 and 80 years 
old were treated with 200 mg-day"1 BC-PS for 3 months, showed that PS 
supplementation reduced cognitive decline in the elderly. In addition, memory and 
verbal ability were significantly improved when compared to placebo, three months 
after dosing ceased. These findings suggest that PS may have effects after the subject 
has stopped taking it, possibly as it may become embedded within membranes, and 
consequently enhance PS concentration within them.
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Cenacchi et al (1993) supplemented 425 elderly subjects, all of which suffered from 
moderate to severe cognitive decline, with 300 mg-day'1 BC-PS for 3 months. The 
Buschke Selective Reminding Test scores of the subjects were significantly improved 
in favour of PS, indicating an improved memory and learning adaptability. Villardita 
et al (1987) found similar effects when supplementing 170 subjects, aged 55 -  80 
years of age, with 300 mg-day'1 BC-PS for 90 days. All subjects suffered from mild 
to moderate cognitive decline, and supplementation significantly improved memory, 
learning, concentration and verbal ability. Crook et al (1992) supplemented 51 
subjects (55 -  85 years of age) for 12 weeks, and BC-PS was shown to enhance 
memory and benefit cognitive function.
The work of Cenacchi et al (1993), Crook et al (1992), and Villardita et al (1987) 
suggested that supplementation with BC-PS may be a feasible treatment to counteract 
the cognitive decline that accompanies old age, and may also act in the early stages to 
prevent/limit such decline.
Research by Palmieri et al (1987) replicated the findings of other work (Villardita et 
a l , 1987; Crook et a l , 1992; Cenacchi et a l , 1993), but did so when supplementing 
for shorter periods of time. Palmieri et al (1987) supplemented 87 subjects (55 -  80 
years of age), all of whom had moderate cognitive deterioration, with 300 mg-day'1 of 
BC-PS for 60 days. Concurrently, BC-PS enhanced memory, and was also found to 
enhance learning sociability and improve daily living, specifically a lessening of 
apathy and withdrawal. Consequently, BC-PS may not only be of benefit by reducing 
cognitive deterioration, but it may also improve the social behaviour of those taking 
it.
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Supplementation with S-PS has been shown to have beneficial effects on younger 
individuals as well as those exhibited in the elderly. Benton et al (2001) found that 
supplementing with 300 mg-day'1 of S-PS for a month was associated with feeling 
less stressed and having a better mood in a sub-group of young healthy adults. Fahey 
and Pearl (1998) showed young males treated with S-PS to display a significantly 
greater feeling of well being after exercise, measured using a 10 point scale, 
following administration of 800 mg-day'1 of S-PS for two weeks.
2.4.2 Phosphatidylserine and exercise
Physically demanding conditions are known to release stress hormones such as 
ACTH and cortisol (Kelly, 1999) into the circulation. While this leads to the release 
of energy that counteracts stress, cortisol has catabolic actions upon protein, which 
can lead to muscle fibres being broken down (Kidd, 1998). Furthermore, cortisol has 
also been shown to have inhibitory effects upon the inflammatory/immune response 
within the body (Tsigos and Chrousos, 2002). Recent research (Table 2) has shown 
that PS may attenuate the release of ACTH and cortisol during and following 
exercise.
Monteleone et al (1990) were among the first researchers to postulate the potential 
benefits of PS with regards to exercise. Acute supplementation, administered 
intravenously, with 50 or 75 mg of BC-PS was shown to blunt the stress hormone 
response to exercise (Monteleone et a l , 1990), with cortisol and ACTH being 
significantly blunted by BC-PS. Chronic oral supplementation of BC-PS (800 
mg-day'1 BC-PS for 10 days) was also shown to significantly blunt the ACTH and
37
cortisol responses to physical stress (Monteleone et a l , 1992). It is possible that the 
response achieved with chronic oral supplementation is dose-dependant, as a dose of 
400 mg-day"1 of BC-PS for 10 days was shown to blunt the cortisol response to 
physical stress, but this did not reach statistical significance, thus suggesting greater 
amounts of BC-PS produce greater effects (Monteleone et al., 1992). This research 
does, however, demonstrate that both single intravenous and chronic oral doses of 
BC-PS blunt the hormonal response to stress in humans.
Chronic oral supplementation with S-PS has been shown to produce similar effects on 
the hormonal response to physical stress. Fahey and Pearl (1998) orally administered 
11 young males with 800 mg-day"1 of S-PS for 14 days, and subjects were required to 
complete 4 intense resistive training sessions a week. Soybean-derived PS was shown 
to significantly blunt the rise in cortisol associated with exercise stress (in comparison 
with placebo), and also blunt ACTH levels. The blunting of the hormonal response to 
physical stress by S-PS was accompanied with a greater feeling of well being coupled 
with lower perceived muscle soreness in those treated with S-PS. The greater feeling 
of well-being exhibited by those treated with S-PS is of particular significance, as it 
suggests that S-PS blunts the corticosteriod (cortisol) response to exercise stress. 
Furthermore, it suggests that S-PS does not suppress vital cortisol functions such as 
the support of gluconeogenesis and suppression of inflammation (Fahey and Pearl, 
1998). Subsequently, it can be postulated that S-PS exhibits similar effects to BC-PS 
with regards to the blunting of the hormonal response to exercise stress.
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2.4.3 Phosphatidylserine and cortisol suppression
Researchers are seemingly in agreement that PS may inhibit the stress-induced 
activation of the HPA axis (Monteleone et al., 1990; Monteleone et al., 1992; Pepeu 
et al., 1996; Fahey and Pearl, 1998). The common consensus is that the mechanism 
for PS suppression of cortisol is to decrease the concentration of cortisol’s principle 
controlling hormone, ACTH (Monteleone et al, 1990; Monteleone et al., 1992; 
Fahey and Pearl, 1998).
It has been hypothesised that PS acts upon CRF receptor interactions, consequently 
reducing/blunting activation of the HPA axis, and subsequently suppressing ACTH 
and cortisol levels (Monteleone et al., 1990; Monteleone et al., 1992). It is plausible 
that PS may alter CRF receptor interactions, and therefore ACTH response to 
exercise, as exogenous PS appears to interfere with the relative viscosities of lipids 
within the cell membrane. This could, in turn, affect the position of membrane 
proteins, and consequently disrupt receptor-ligand interactions (Monteleone et al., 
1990; Monteleone et al., 1992). The disruption of such receptor-ligand interactions 
hypothetically leads to a reduced activation of CRF, and consequently a reduced 
activation of the HPA axis (Monteleone et al., 1990).
As highlighted by Monteleone et al (1990), it is only possible to hypothesise on the 
possible mechanisms by which PS blunts the ACTH and cortisol responses to 
exercise. While the hypothesis that PS blunts cortisol production by altering CRF 
receptor interactions (Monteleone et al., 1990; Monteleone et al., 1992) remains a 
plausible one, it is not the sole hypothesis. Other potential mechanisms by which PS
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may attenuate cortisol production include the actions of PS upon the neurotransmitter 
systems involved in the regulation of the HPA axis (Tuomisto and Mannisto, 1985; 
cited in Monteleone et al., 1992). It has been shown, in rodents, that PS enhances 
noradrenaline turnover and release (Toffano and Bruni, 1980; cited in Monteleone et 
al., 1992), which consequently may be responsible for the blunting effect of PS on the 
hormonal response to exercise stress (Monteleone et al., 1990).
2.4.4 Phosphatidylserine and heart rate
The ability of PS to influence HR recovery after exercise could be of great benefit to 
intermittent sports such as soccer, which have frequent periods of active and passive 
recovery; the 15 min half-time break in a soccer match could hypothetically allow for 
a large degree of recovery in HR. The further an individual’s HR can recover during 
any break, the greater their performance (hypothetically) will be after such a break; as 
such PS may have ergogenic effects (which may be of greatest benefit in intermittent 
events).
Investigations on anaesthetized rats have demonstrated that administration of 75 -150 
mg-kg'1 of BC-PS (in the form of liposomes) caused a large increase in acetylcholine, 
the parasympathetic hormone responsible for slowing HR (Casamenti et al., 1979). 
Consequently, the addition of PS to the body may have direct effects on the central 
nervous system and HR control, although it is unclear if such an effect is replicated 
on exercising humans. Furthermore, it is plausible that S-PS supplementation may 
indirectly affect HR. Phosphatidylserine is known to decrease stress hormone levels 
during exercise stress (Monteleone et al., 1990; Monteleone et al., 1992; Fahey and
41
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Pearl, 1998), and this may subsequently reduce the level at which the individual 
perceives they are working at. Consequently, a reduction in perceived exertion may 
lead to an autonomic reduction of HR. With no supplementation, no such reduction in 
perceived exertion would occur, and subsequently no reduction in HR. The effects of 
S-PS supplementation on an exercising HR are novel, and require further 
investigation.
2.4.5 Phosphatidylserine, muscle damage and DOMS
PS supplementation has been shown to reduce perceived muscle soreness (Fahey and 
Pearl, 1998), a frequently used indicator of DOMS. The potential reduction of muscle 
damage, and subsequent reduction of DOMS, by supplementing with PS has both 
long and short-term beneficial possibilities. Fahey and Pearl (1998) hypothesised that 
the suppression of cortisol by S-PS is responsible for the reduction in DOMS, as 
indicated by a reduced perception of soreness, exhibited in their study. Suppression of 
cortisol would limit its catabolic effects, which focus particularly upon muscle 
protein, and subsequently muscle degradation (damage) may be attenuated, or 
prevented all together (Fahey and Pearl, 1998). In addition, suppression of cortisol 
would suppress the inhibitory effect of cortisol on the inflammatory/immune response 
(Tsigos and Chrousos, 2002), theoretically allowing any muscle damage to be treated 
appropriately.
Moreover, PS may have the potential to prevent/limit muscular breakdown by 
becoming embedded in the membrane, consequently stabilising it. Such behaviour 
would also reduce the damage that any ROS may cause by lipid peroxidation of a
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membrane, which can propagate a chain reaction that, in turn, can seriously damage 
cell membranes (Hancock, 1999). Damage to cell membranes may disrupt the 
permeability barrier provided by the sarcolemma, thus permitting abnormal diffusion 
of molecules (calcium ions (Ca2+) and intramuscular enzymes) down their respective 
concentration gradients (Armstrong et a l , 1991), something which the stabilising 
nature of PS might possibly address.
Phosphatidylserine is found predominantly in the inner monolayer of a membrane 
(Devaux, 1991). The most credible mechanism by which exogenous PS (such as that 
ingested orally) reaches the inner monolayer is by moving across the bilayer. 
Carruthers and Melchior (1986; 1988) suggested that lipids (such as PS) can undergo 
rotational, lateral (along a bilayer), and transverse (across a bilayer) movements. 
Additionally, Devaux (1991) stated 5 methods for the transverse movement of lipids 
within biomembranes: (1) simple diffusion, (2) facilitated diffusion, (3) active 
transport, (4) lipid segregation by pH, and (5) lipid (re)distribution. In the plasma 
membranes of eukaryotes, the lipid bilayer asymmetry appears to be maintained by 
active transport of lipids to counterbalance spontaneous lipid diffusion (Devaux,
1991). However, it remains plausible that the transverse movement of PS to the inner 
monolayer may follow any of the aforementioned methods.
Acidic phospholipids such as S-PS, phosphoglycerol (PG) and phosphatic acid (PA) 
have the ability to bind free iron, and thus potentially quench ROS (Dacaranhe and 
Terao, 2001). The polar nature of the serine head group of PS takes up a zwitterion 
structure, which means that it has separate areas of positive and negative charge 
(Vance and Vance, 1996). This may be significant in the prevention of muscle
43
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damage during/following exercise where the participant is at risk of oxidative stress, 
such as a soccer match, as the zwitterionic nature means that S-PS can plausibly act 
as an antioxidant and thus ‘quench’ ROS before damage can occur. S-PS could act as 
an antioxidant because the amide group (NH3*), the positively charged section of the 
serine head group, can feasibly accept free electrons from ROS, thus deactivating 
them. However, of this group, only S-PS has demonstrated an antioxidant activity in 
eukaryotic cells (Dacaranhe and Terao, 2001), making it credible that S-PS 
supplementation may enhance an individual’s antioxidant defences. Furthermore, 
Latorraca et al (1993) have shown exogenous PS to reduce the effects of free radical 
damage on human cells in in-vitro preparations. Consequently, it is plausible that S- 
PS may reduce muscle damage in this manner, as shown by reduced muscular 
soreness (Fahey and Pearl, 1998).
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3.1 Subjects
16 male subjects volunteered to take part in this study, which had Department of 
Psychology Ethical Committee Approval, University of Wales Swansea (Appendix 
A). Subjects were all University soccer players, who trained/competed a minimum of 
3 times a week. All subjects were non-smokers. The mean ± standard error of the 
mean (SEM) values for age, height, body mass, and estimated maximal oxygen 
uptake (V  0 2 max) of the subjects were 22.12 ± 0.4 years, 1.81 ± 0.02 m, 77.8 ± 1.9 kg, 
and 53.7 ±1.3 ml-kg'^min' 1 respectively (Table 3).
All subjects were informed in writing (Appendix B) about the requirements of the 
study. Furthermore, the demands of the study were fully explained verbally. All 
subjects subsequently gave written informed consent (Appendix C) and filled in 
health questionnaires (Appendix D).
3.2 Study Design
Subjects firstly completed a preliminary multi-stage fitness test (MSFT), in order to 
determine individual V Oimax- Subjects then completed an exercise protocol, designed 
to simulate soccer match play, on three separate occasions. The first trial was used to 
familiarise the subjects with the protocol, after which subjects were assigned, in a 
double blind randomised fashion, to one of two groups (PS or Placebo).
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Subjects then completed two main trials (T1 and T2) (Figure 2), and were 
administered with S-PS (750 mg-day'1) or a glucose placebo for 10 days prior to T2.
All trials were conducted in the same wooden floored gymnasium. Furthermore, T1 
and T2 were completed at a similar time of the morning (within 1 hour), and air 
temperature and humidity were assessed for all trials using a digital thermometer. In 
addition, subjects exercised in pairs matched by predetermined V Chmax, consisting of 
one subject from each group.
3.3 Exercise Protocol
The exercise protocol consisted of two parts, part A and part B. Part A was of a fixed 
duration (90 min) and consisted of 15 x 4 min bouts of exercise, separated by passive 
recovery periods. The recovery periods were 1 min in length, with the exception of 
the ‘half time’ break, which was 15 min long, and included after 45 min (Figure 3). 
Prior to commencing part A, the subjects completed a set warm-up as outlined in 
Appendix E. Part A of the exercise protocol involved a repeated cycle of exercise 
(Figure 4), which consisted of walking, sprinting, zigzag running, jogging (55% 
V C>2max), backward jogging (55% V 0 2 max) and cruising (85% V C>2max) for different 
lengths of time. The running speeds were dictated by timed signals on a CD (audible 
beeps). The proportion of time and distance for each activity was developed to 
simulate the physiological demands of a soccer match, thus replicating the amount of 
time and distance spent on each activity during a game. This was developed with 
reference to notational analysis work on elite level soccer (Reilly and Thomas, 1976;
47
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Bangsbo et al., 1991; Reilly, 1997) and previous attempts to simulate soccer match 
play (Nicholas et a l , 2000). Part B comprised of the MSFT, a progressive maximal 
shuttle run test used to assess endurance (Ramsbottom et al., 1988). Part B followed 
immediately after the 1 min recovery period at the end of part A (on 75 min), as 
indicated in figure 3, and was expected to last 10-15 min. Following completion of 
the protocol, the subjects completed a cool down, which was identical to the warm up 
(Appendix E).
3.4 Preliminary Measurements
The aerobic fitness of each subject was estimated using the MSFT (Ramsbottom et 
al, 1988). Subjects ran between two points 20 m apart, and running speeds were 
dictated by timed signals on a CD (audible beeps). The MSFT continued until 
volitional exhaustion, or until the subject missed three beeps at the same end. The 
shuttle level achieved was used to calculate the subject’s V 0 2 maxs using linear 
regression (Ramsbottom et al., 1988). Subjects were assigned to the running speed of 
exercise protocol closest to their V C^ max, in order to ensure they worked at 
equivalent relevant exercise intensities.
Immediately prior to familiarisation, subjects’ mass (model 712; Seca, Germany) and 
height (portable stadiometer; Holtain, UK) were measured. Each subject underwent a 
familiarisation session, in which they completed the exercise protocol, in order to 
minimise any possible trial-order effect.
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3.5 Main Trial Procedures
Prior to exercise, the subjects were required to fast for at least 4 hours, and complete 
a 24-hour dietary record in order to record dietary intake. Subjects were requested to 
replicate their diet before T1 and T2, and dietary records were undertaken to confirm 
this. Subjects were also required to abstain from additional exercise and alcohol in the 
24 hours prior to exercise, and in the 48 hours post-exercise. For the 10 days prior to 
T2 subjects were supplemented orally with either 750 mg-day’ 1 of S-PS or a weight 
matched glucose placebo. The S-PS supplement used in this study was commercially 
produced by Lucas Meyer, and consisted of a blend of concentrated S-PS and 
soybean lecithin that gave a final concentration of 20% PS.
Subjects were encouraged to drink water ad libitum during their Tl. The amount of 
water consumed in Tl was measured and the subjects given the same amount of 
water to drink in T2.
Subjects were required to indicate perceived muscle soreness using an 11-point 
questionnaire (Appendix F) prior to exercise, 20 min after completion, and at 24 and 
48 hours after exercise.
Venepuncture blood samples were taken 20 min prior to exercise (PE), and 20 min 
following completion of exercise (PST). Additional capillary blood samples were 
collected from a fingertip at half-time (h/t) and immediately following completion of 
the protocol (Imm PST). Further intravenous blood samples were taken 24 hours (24 
Hr) and 48 hours (48 Hr) after exercise (within 1 hour of initial trial time).
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During the exercise protocol, heart rate (HR) was recorded every 5 s using short- 
range telemetry (810s; Polar, Finland). Rate of Perceived Exertion (RPE) was 
assessed at h/t and upon completion of exercise (Imm PST) using the Borg scale 
(Appendix G), and ecological validity was assessed upon completion of exercise 
(Appendix H). Recovery from exercise was assessed 24 Hr and 48 Hr post-exercise, 
and subjects were instructed to abstain from exercise until this was completed.
3.6 Blood Sampling and Analysis
Venepuncture blood samples were taken by a trained individual, after the subject had 
been in a seated position for approximately 10 min. Samples were collected from an 
antecubital vein using a sterile needle (21 gauge precision needle; Becton-Dickinson 
Ltd, UK) and vacuum tubes, with approximately 30 ml of blood being collected on 
each occasion.
Approximately 10 ml of blood was collected in an EDTA vacutainer (Becton- 
Dickinson Ltd, UK). Whole blood was immediately removed and analysed in 
triplicate for lactate and glucose concentrations, using a YSI 2300 STAT PLUS 
analyser (YSI inc, Ohio, USA). Triplicate blood haemoglobin concentrations were 
measured using an automated photometric analyser (Hemocue; UK), whilst triplicate 
blood haematocrit levels were measured using a haematocrit reader, following 5 
minutes of centrifuging (Micro Haematocrit mk IV; Hawksley and Sons Ltd, 
England). Changes in plasma volume (PV) from pre-exercise values were then 
calculated according to the method of Dill and Costill (1974).
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Approximately 20 ml of blood was collected in Serum Separation Tubes (Becton- 
Dickinson Ltd, UK), which were left to stand for 30 min. All blood samples (SST and 
EDTA) were then spun in a centrifuge (Labofuge 200; Kendro, Germany) at 3000 
rpm for 15 min. A portion of the blood plasma (100 |Jl) was added to 900 |Jl of 10% 
metaphosphoric acid, mixed, and frozen for vitamin C analysis. Blood serum and 
plasma samples were then dispensed and immediately frozen at -70°C, prior to 
further analysis. The process of cell separation was always completed within 1 hour 
(from the time blood was collected until the time of freezing).
Serum creatine kinase (CK) concentrations were determined using a commercially 
available reagent (CK-NAC 10 - Ref. A11A00008, ABX Diagnostics, Bedfordshire, 
UK) and the Cobas MIRA S automated spectrometer (ABX Diagnostics, 
Bedfordshire, UK). Triplicate measurements were made, and a mean serum CK value 
calculated for each time point. Total serum cortisol analysis was performed on an 
AutoDELFIA system (PerkinElmer, Life Sciences), using a time-resolved 
fluoroimmunoassay. Lipid hydroperoxide (HPO) concentrations were measured using 
the method of Wolff (1994), as described by McEneny et al. (1998). Vitamin C 
concentrations were determined using a fluorimetric assay, using a centrifugal 
analyser with fluorescence attachment according to the method of Vuilleumier 
(1993). Plasma concentrations of vitamin E were measured by liquid 
chromatography, following the methods of Catignani and Bieri (1983) and Thumham 
et al (1988).
Capillary blood samples, taken at half-time (h/t) and immediately post exercise (Imm 
PST), were collected from a fingertip. The skin on the chosen finger was disinfected
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using an alcohol swab, and then pricked using an Accu-check Softclix Pro (Roche 
Products Ltd, UK) and lancet (Roche Products Ltd, UK). Blood was then collected in 
a heparinised capillary tube (Hawksley and Sons Ltd, UK), and blood lactate and 
glucose concentrations were analysed as previously described.
3.7 Statistical Analysis
Statistical analysis was carried out using SPSS (version 11.0; SPSS, IL, USA). All 
group values are expressed as mean ± standard error of mean (SEM). Significance 
for all statistical analysis was set at the 5% level (P<0.05). Markers of muscle 
damage, oxidative stress, and cortisol response were compared using a 3-way (trial x 
time x supplement) mixed model analysis of variance (ANOVA), as were blood 
lactate and glucose concentrations. If a significant P value was identified for the main 
effect of time (time of sample), multiple pairwise comparisons were made using 
Bonferroni confidence interval adjustment. The MSFT performance was compared 
using a 2-way (trial x supplement) mixed model ANOVA. Independent samples t- 
tests were used to compare PS and placebo group’s characteristics prior to testing. 
Sprint performance, HR response, and environmental conditions during trials 1 and 2 
were also compared using independent samples Mests. In all cases, a significant 
interaction effect (PO.05) was taken to signify that the PS group reacted differently 
to the placebo group.
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4 Results
4.1 Environmental Conditions
There were no significant differences in the ambient temperature (trial effect, P=0.79) 
or humidity (trial effect, P=0.41) between trials, with ambient temperatures being
19.6 ± 0.5 and 21.4 ± 0.4 °C, and humidity 50.5 ±1.8 and 53.9 ± 1.9%, during trial 1 
and 2 respectively. As the subjects ran in pairs of mixed groups (one PS with one 
placebo) there were no differences between the environmental conditions for 
supplementation groups.
4.2 Heart Rate Response to Exercise
Figure 5 demonstrates the HR trace for a representative subject throughout the 
exercise protocol, where the minimum and maximum values were 93 and 204 
beats-min'1, respectively. Peak HR occurred upon completion of part B of the 
protocol for all subjects (Figure 5). Table 4 displays mean heart rate (HR) values for 
the supplementation groups. There was no significant difference between the mean 
HR (of all subjects) in trials 1 and 2 (2 way interaction effect, P=0.687). Peak HR 
were similar during trials 1 and 2 (trial effect, P=0.805) in both supplementation 
groups (Table 4). Furthermore, no significant trial x supplement interaction on peak 
HR was identified (P=0.626).
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Mean h/t HR data were similar during trials 1 and 2 (temporal effect, P=0.961) in 
both supplementation groups (Table 4); mean h/t HR for all trials being 
100 ± 4 beats-min'1. Furthermore, there was no significant trial x supplement 
interaction on mean h/t HR (P=0.831).
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4.3 Exercise Performance
Significant rises in Rate of Perceived Exertion (RPE) were seen from half time to 
full-time during all trials (temporal effect, PO.OOl). Furthermore, RPE was highest 
at full-time for both PS, being 18.0 ± 0.7 and 17.8 ± 0.8 for trials 1 and 2 
respectively, and placebo, being 17.4 ± 0.5 and 17.1 ± 1 for trials 1 and 2 
respectively. Supplementation with PS had no significant effect upon RPE (trial x 
time x supplement interaction, P=0.515) at any point during or after exercise.
Individuals in the PS group performed (on average for all trials) 16% better than 
those taking a placebo (Figure 6 ), mean MSFT decimal level scores for trial 2 being
11.6 ± 0.7 and 10.9 ± 0.8 respectively. The trial x time x supplement interaction 
approached significance (P=0.082).
The mean sprint speeds and peak sprint speeds for PS and placebo groups during trial 
1 and trial 2 are shown in Table 5. Supplementation with PS had no significant effect 
upon mean sprint speed (trial x supplement interaction, P=0.273) or peak sprint speed 
(trial x supplement interaction, P=0.370).
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4.4 Blood Analysis
Calculated changes (from pre-exercise trial 1 values) in plasma volume (PV) were 
similar for both PS and placebo groups (Table 6 ), and no significant trial effect 
(P=0.351) or supplement effect (P=0.651) were identified.
Blood lactate concentrations were significantly elevated by exercise (temporal effect, 
PO.OOl) and peaked immediately post exercise (Figure 7). Peak values for trial 1 
were similar for both groups, being 6.0 ± 0.3 and 6 . 6  ± 0.6 mmolT1 for PS and 
placebo respectively. Additionally, trial 2 peak lactate values were similar for PS and 
placebo groups, being 6.1 ± 0.4 and 5.7 ± 0.3 mmolT1, respectively. No significant 
trial x time x supplement interaction was identified (P=0.209).
Blood glucose was significantly elevated by exercise (temporal effect, PO.OOl), and 
peaked immediately post-exercise (Figure 8 ). Peak blood glucose concentrations were
5.4 ± 0.2 and 5.3 ± 0.3 mmolT1, for PS and placebo respectively, during trial 1, and 
5.3 ± 0.3 and 5.1 ± 0.2 mmolT1, for PS and placebo respectively, during trial 2. 
Blood glucose concentrations had returned to pre-exercise levels 20 minutes after 
exercise (Figure 8 ). The trial x time x supplement interaction was not significant 
(P=0.815).
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4.5 Cortisol Response to Exercise
Serum cortisol concentration increased with exercise (temporal effect, PO.OOl), and 
peaked 20 minutes post-exercise (Figure 9). Pre-exercise cortisol levels in trial 1 were 
386 ± 25.0 and 397 ±11.5 nmolT1, and peak values 489 ± 69.8 and 591 ±31.9 
nmolT1, for PS and placebo respectively. Pre-exercise cortisol concentrations in trial 
2 were 348 ± 38.6 and 470 ±51.7 nmolT1, and peak values 470 ± 47.2 and 507 ± 
36.2 nmolT1, for PS and placebo respectively.
Cortisol concentrations were significantly below pre-exercise levels 24 hours after 
exercise for all subjects. However, individuals supplemented with PS demonstrated a 
possible enhanced recovery (trial x time x supplement interaction, P=0.199). Cortisol 
concentration decreased on average by 47.2% for the PS group, compared with an 
average of 32.9% for the placebo group (Figure 9).
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4.6 Indicators of Muscle Damage
Serum creatine kinase (CK) activities were significantly elevated (temporal effect, 
PO.OOl) 20 minutes after exercise in all trials, and peaked after 24 hours of recovery 
(Figure 10). Peak values during trial 1 were 627 ±122 and 743 ±142 UT1 for PS and 
placebo respectively; peak values during trial 2 were 476 ± 98.3 and 413 ± 53.0 UT1 
for PS and placebo respectively. Serum CK activities had returned to pre-exercise 
levels 48 hours after exercise in all trials (Figure 10). No significant trial x time x 
supplement interaction was identified (P=0.674).
Perceived general muscle soreness was significantly elevated by exercise (temporal 
effect, PO.OOl) and peaked 20 minutes after exercise (Figure 11). Peak soreness 
levels during trial 1 were 3.6 ± 0.6 and 5.1 ± 0.6, for PS and placebo respectively; 
peak soreness levels during trial 2 were 2.6 ± 0.7 and 3.7 ± 0.6, for PS and placebo 
respectively. Soreness levels had returned to pre-exercise levels 48 hours after 
exercise (Figure 11). Individuals supplemented with PS tended to report lower levels 
of soreness than those supplemented with a placebo, being on average 9 and 31% 
lower during trial 2, after 24 and 48 hours of recovery respectively. No significant 
trial x time x supplement interaction was identified (P=0.616).
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4.7 Indicators of Oxidative Stress
|
i
Serum lipid hydroperoxide (HPO) concentrations were significantly elevated by 
exercise (temporal effect, PO.OOl), and peaked 20 minutes after exercise (Figure 
12). Peak HPO concentrations during trial 1 were 1.11 ±0.1 and 0.99 ±0.1 jjmoH'1, 
for PS and placebo respectively; peak HPO concentrations during trial 2 were 1.15 ± 
0.1 and 0.98 ±0.1 jJmoM'1, for PS and placebo respectively. HPO concentrations had 
returned to pre-exercise levels within 24 hours of exercise (Figure 12), and no 
significant trial x time x supplement interaction was identified (P=0.495).
Plasma vitamin C concentrations increased with exercise (temporal effect, P0.001), 
and were significantly elevated 20 minutes after exercise for all subjects (Figure 13). 
Peak plasma vitamin C concentration occurred 24 hours post-exercise for the placebo 
group, yet did not peak until 48 hours post-exercise in the PS group (Figure 13). Peak 
plasma vitamin C concentrations during trial 1 were 45.4 ± 4.9 and 50.9 ± 7.8 
|JmoM_1, for PS and placebo respectively; peak plasma vitamin C concentrations 
during trial 2 were 42.3 ± 4.5 and 44.8 ± 6.5 iJmoH'1, for PS and placebo 
respectively. No significant trial x time x supplement interaction was identified 
(P=0.568).
Plasma vitamin E concentrations were unaffected throughout the trial (Figure 14), 
with only PS trial 1 and placebo trial 2 being significantly elevated from pre-exercise 
values (temporal effect, P=0.022). Peak plasma vitamin E concentrations occurred 20 
minutes post exercise for all subjects (Figure 14). Peak plasma vitamin E
72
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concentrations during trial 1 were 28.4 ±1.8 and 27.9 ±1.4 pmolT1, for PS and 
placebo respectively; peak plasma vitamin E concentrations during trial 2 were 29.6 ±
t
1.5 and 28.5 ±1.9 pmoH'1, for PS and placebo respectively. No significant trial x
i
time x supplement interaction was identified (P=0.600).
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4.8 Ecological Validity
The vast majority (79%) agreed that the protocol provided an excellent replication of 
soccer match play (Table 7). Furthermore, 41% of all subjects disagreed that the 
protocol was significantly easier than a soccer match. Subjects were of mixed opinion 
as to whether the protocol consisted of too frequent rest breaks, but were in 
agreement that the length of the rest periods was correct.
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5 Discussion
This study measured the influence of chronic soybean-derived phosphatidylserine (S- 
PS) supplementation (750 g-day' 1 for 10 days) on exercise performance and markers 
of exercise stress, muscle damage and oxidative stress during and following 
prolonged intermittent exercise that was designed to simulate soccer match play. 
Supplementation with S-PS had no significant effect upon the elevation of blood 
cortisol, oxidative stress or muscle damage associated with prolonged intermittent 
exercise.
The average heart rate (HR) during the protocol (143 ± 3.9 beats-min'1) was below 
the range of 160 -  180 beats-min' 1 demonstrated by Ekblom (1986) and the average 
of 165 beats-min' 1 stated by Reilly (1997). However, the average peak HR of 195.9 ± 
2 . 1  beats-min' 1 was above these values, suggesting that the subjects’ work rate 
encompassed the values previously reported. The peak blood lactate concentration 
(5.90 ± 0.25 mmolT1) was similar to the values that have been previously reported 
for soccer match play (Ekblom, 1986; Gerisch et a l , 1988; Bangsbo et al., 1991), 
suggesting that the protocol elicited a similar anaerobic response to soccer match 
play. Furthermore, Ekblom (1986) demonstrated blood lactate concentrations to be 
higher at more intense levels of competition, and values from this study concurred 
with values for 3rd and 4th division players (Ekblom, 1986). The individuals used in 
this study were not professional sportsmen, and therefore do not compete at the 
highest levels of soccer, offering a plausible explanation for the slightly lower values 
demonstrated in this study.
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The distance covered during exercise varied depending upon part B performance, but 
a range of 11 -  12 km was recorded, which is concurrent with the range of 8  -  13 km 
calculated by Reilly and Thomas (1976), although slightly higher than average values 
of other researchers (Bangsbo et a l, 1991; Tumility, 1993). Furthermore, 79% of 
subjects felt that the protocol provided an excellent replication of soccer match play, 
as measured by an ecological validity questionnaire. Consequently, the protocol 
appeared to replicate the physiological and psychological demands of soccer match 
play.
Serum cortisol concentrations peaked 20 min after exercise and returned to pre­
exercise levels following 24 hours of recovery. The time-scale of this response is 
concurrent with previous research of a similar exercise-type and subject group 
(Thompson et a l , 2001); consequently, the exercise protocol led to an exercise- 
induced activation of the hypothalamo-pituitary-adrenal (HPA) axis (Axelrod and 
Reisine, 1984). Exercise stress induces the hypothalamic secretion of a corticotropin- 
releasing factor (CRF) (Tsigos and Chrousos, 2002), which in turn stimulates the 
release of adrenocorticotropic hormone (ACTH) by the pituitary gland (Axelrod and 
Reisine, 1984; Tsigos and Chrousos, 2002). Consequently, ACTH is then transported 
in the blood to the adrenal cortex, where the increased concentrations of ACTH 
initiate the synthesis and release of cortisol (Axelrod and Reisine, 1984; Tsigos and 
Chrousos, 2002). The elevated levels of cortisol within the blood then stimulate the 
catabolism of proteins in order to synthesise glucose (Tortora and Anagnostakos, 
1987; Kelly, 1999; McArdle et a l , 2000) and biosynthetic enzymes like 
phenylethanolamine TV-methyltransferase (PNMT), which is responsible for the
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conversion of noradrenaline to adrenaline within the adrenal gland (Axelrod and 
Reisine, 1984).
During trial 2 the serum cortisol concentrations of those supplemented with S-PS rose 
by 26% from pre-exercise to peak cortisol concentrations, in comparison with a rise 
of 8 % exhibited by the placebo group for the same time-span. It is credible that this 
response in cortisol was a direct result of the exercise performance of the 2  groups; 
the PS group performed on average 16% better than the placebo group during part B 
of the protocol, and although no significant supplement effect was identified, this did 
approach significance (P=0.082). Therefore, previous reports that PS supplementation 
blunted the cortisol response to physical stress (Monteleone et al., 1990; Monteleone 
et a l , 1992; Fahey and Pearl, 1998) were not replicated during this study. It is 
plausible that the prolonged intermittent nature of the exercise was a further reason 
why previous findings were not replicated in this study; previous research has 
investigated PS supplementation using either shorter durations (20 min) of 
intermittent cycling (Monteleone et a l , 1990; Monteleone et a l , 1992) or 2 weeks of 
resistance training (Fahey and Pearl, 1998). Consequently, the continued and 
cumulative increase in cortisol throughout 90 min of intermittent exercise may be too 
much for S-PS supplementation to attenuate. Additionally, it is possible that the 
number of subjects for S-PS and placebo groups was not large enough to demonstrate 
a significant response, although previous research using similar subject numbers has 
demonstrated the ability of PS to blunt the hormonal response to exercise 
(Monteleone et al, 1990; Monteleone et a l, 1992).
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Moreover, previous research has suggested that a potential dose-dependant response 
to chronic PS supplementation exists (Monteleone et a l , 1992), and this presents a 
possible reason why the supplementation routine used in this study did not attenuate 
the cortisol response to physical stress. Monteleone et al (1992) showed that chronic 
oral supplementation with 800 mg-day' 1 BC-PS for 10 days significantly blunted the 
ACTH and cortisol responses to exercise, while a dose of 400 mg-day' 1 of BC-PS for 
10 days did not reach statistical significance. The supplementation routine used in this 
study gave subjects 750 mg-day' 1 of S-PS for 10 days, and it may be that this amount 
of S-PS was insufficient to replicate the findings of a similar supplementation routine 
conducted with BC-PS (Monteleone et a l , 1992). Additionally, the supplementation 
routine used in this study was similar in type (S-PS), but lower in dosage, to that used 
by Fahey and Pearl (1998), who showed oral supplementation with 800 mg-day' 1 S- 
PS for 14 days to successfully attenuate the cortisol response to exercise.
The trend towards enhanced performance demonstrated by those supplemented with 
S-PS was most prominent during part B of the exercise protocol, where the S-PS 
group performed on average 16% better (P=0.082). Consequently, this trend towards 
enhanced performance provides the most credible reasoning as to why ACTH and 
cortisol responses were not blunted by S-PS supplementation during this study. Since 
the individuals supplemented with S-PS demonstrated this trend towards enhanced 
performance, and subsequently enhanced cortisol concentrations, it becomes difficult 
to quantify if S-PS affected the cortisol response to exercise. Furthermore, it is 
possible that any effect of S-PS to attenuate the cortisol response to exercise was 
masked by the (trend towards) improved performance.
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j The post exercise increases in serum creatine kinase (CK) activity and perceived
general muscle soreness indicated that both muscle damage and delayed onset muscle 
soreness (DOMS) occurred at some point during the exercise protocol. Post-exercise 
increases in these indicators of muscle damage were in agreement with previous 
research (Thompson et al., 1999; Thompson et a l, 2001; Wadsworth et al., 2004). 
Moreover, the familiarisation session succeeded in eliminating any trial-order effect, 
and consequently the exercise protocol led to muscle damage and DOMS despite 
prior exposure to the test.
Supplementation with S-PS had no significant effect on indicators of muscle damage 
and DOMS; consequently the findings of previous research (Fahey and Pearl, 1998) 
were not replicated. Fahey and Pearl (1998) demonstrated that oral supplementation 
with S-PS (800 mg-day*1 PS for 14 days) reduced perceived muscle soreness during a 
2 week resistance-training programme. It is possible that the reduced perceived 
muscle soreness demonstrated by Fahey and Pearl (1998) was associated with the 
attenuation of the cortisol response to exercise, also demonstrated in the same study. 
Cortisol is known to have catabolic properties, and inhibit the inflammatory/immune 
response (Tsigos and Chrousos, 2002). Therefore, any muscle degradation occurring 
during exercise would, in theory, be left untreated. Moreover, cortisol levels elevated 
by exercise may in turn emphasise any muscle degradation or damage that occurs. 
This study did not show S-PS to attenuate the cortisol response to exercise, and 
consequently the catabolic activities of cortisol might be considered a potential 
explanation to the elevated levels of muscle damage and DOMS demonstrated.
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Individuals supplemented with S-PS demonstrated a tendency towards a lower 
perception of general muscle soreness, being on average 23% lower, and although no 
significant supplement effect was identified, this did approach significance 
(P=0.067). The trend towards a lower perceived general muscle soreness in the PS 
group suggests that supplementation may have had some effect on the individuals, be 
it psychological, as proposed by Fahey and Pearl (1998), or physiological as 
hypothesised by in-vitro research (Latorraca et a l , 1993; Dacaranhe and Terao, 
2001).
The response of serum lipid hydroperoxide (HPO) concentrations suggested that the 
protocol elicited oxidative stress. Elevated reactive oxygen species (ROS) production 
occurs as a result of exercise stress (Kanter, 1994). Where antioxidant defences 
become saturated ROS lead to an increase in oxidative stress (Sen, 1995). 
Consequently, increased lipid peroxidation occurs as a direct result of the exercise 
protocol and HPO is released as a by-product of this process (Brites et a l , 1999; 
Child et a l , 1999). Supplementation with S-PS had no effect upon serum HPO 
concentrations, and consequently lipid peroxidation and oxidative stress were 
unaffected by S-PS supplementation. However, the trend towards enhanced 
performance, as demonstrated by the S-PS group in part B of the protocol, makes it 
difficult to quantify if the antioxidant properties of S-PS were insufficient to 
prevent/reduce oxidative stress, or merely masked by the improved performance (and 
consequent potential elevation in oxidative stress experienced by this group).
Additionally, the elevated concentrations of plasma vitamin C also suggest that the 
protocol elicited oxidative stress. Elevated plasma concentrations of vitamin C, an
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antioxidant, were probably a result of its mobilization from tissue storage to plasma 
circulation, in order to counter-act oxidative stress (Alessio et a l , 1997; Brites et al., 
1999; Thompson et a l , 2001; Urso and Clarkson, 2003). It is also plausible that 
elevated plasma concentrations of vitamin E, another antioxidant, were in part due to 
the ability of vitamin C to regenerate vitamin E, again in order to counter-act 
oxidative stress (Brites et a l, 1999; Urso and Clarkson, 2003). Therefore, oxidative 
stress might be at least partially responsible for the muscle damage, and subsequent 
soreness, demonstrated in this study.
Indicators of oxidative stress and antioxidant markers were all unaffected by S-PS 
supplementation. Accordingly, the findings of previous in-vitro research (Latorraca et 
a l , 1993; Dacaranhe and Terao, 2001) were not supported by this study. Latorraca et 
al (1993) showed that exogenous PS reduced the effects of free radical damage on 
human cells in in-vitro preparations, whilst Dacaranhe and Terao (2001) found S-PS 
to be the only acidic phospholipid to demonstrate an antioxidant activity in eukaryotic 
cells. It is proposed that PS may act as an antioxidant by binding with free iron, and 
therefore quenching ROS (Dacaranhe and Terao, 2001), and in-vitro studies have 
supported this proposal (Latorraca et a l, 1993; Dacaranhe and Terao, 2001). The 
comparatively low antioxidant defences of skeletal muscle (Sen, 1995) make these 
tissues particularly susceptible to oxidative damage during exercise stress (Armstrong 
et a l, 1991), when there is a subsequent increase in ROS production (Kanter, 1994). 
However, the suggestion that those supplemented with S-PS in this study worked 
harder makes it difficult to assess the effectiveness of S-PS supplementation was 
effective in attenuating oxidative stress during this study. However, elevated 
anaerobic work rate, as exhibited in this study by the PS group, is known to lead to
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increased ROS production (Sen, 1995; Urso and Clarkson, 2003), subsequent lipid 
peroxidation and cell damage (Sumikawa et a l , 1993). Consequently the response of 
serum CK activities and HPO concentrations also support the proposal that those 
supplemented with S-PS worked harder in the second trial.
It is plausible that the potential ergogenic effects of S-PS supplementation suggested 
in this study are due to the known psychological benefits of S-PS supplementation. 
Previous research has shown S-PS to significantly enhance feelings of well being 
(Fahey and Pearl, 1998) during the physical stress brought about by exercise. This 
could in turn lead to a lower perception of work rate, subsequently leading to the 
enhanced performance demonstrated by the PS group. The potential for chronic 
supplementation with S-PS to act as an ergogenic aid is a novel finding, which 
presents much scope for further investigation.
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6 Conclusions
6.1 Conclusions
Evidence exists to suggest that soccer players are at risk of oxidative stress, muscle 
damage and delayed onset muscle soreness (DOMS) following a soccer match. The 
current findings confirmed that prolonged intermittent exercise designed to simulate 
soccer match play led to elevations in markers of oxidative stress, muscle damage and 
DOMS. Furthermore, these markers were affected to an equal extent in placebo and 
S-PS groups, and returned to pre-exercise levels within 48 hours.
However, those supplemented with S-PS demonstrated a trend towards enhanced 
performance. Individuals supplemented with S-PS demonstrated a tendency in trial 2 
to perform better in part B of the protocol. Moreover, higher work rates have been 
consistently shown to elevate markers of stress and muscle damage; during trial 2  the 
PS group demonstrated a tendancy for higher levels of serum cortisol concentration, 
lipid hydroperoxide concentration, and serum creatine kinase activity. It is plausible 
that the trend of improved performance of the PS group, and consequent elevation in 
serum cortisol concentration and oxidative stress markers, may have negated any 
benefits that S-PS supplementation had on these markers. Therefore, future research 
should attempt to clarify the potential ergogenic effect of S-PS supplementation, and 
ascertain if such supplementation has any effect on the elevation of blood cortisol and 
oxidative stress associated with prolonged intermittent exercise.
87
conclusions
6.2 Limitations and Future Recommendations
The propensity for S-PS supplementation to improve performance presents a novel 
finding in this study; however, it also presents the biggest limitation of the study. It is 
plausible that the tendency for improved performance of the S-PS group, and 
consequent elevation in markers of stress, muscle damage, and oxidative stress, may 
have negated any benefits that S-PS supplementation had on these markers. 
Therefore, future research is warranted to clarify if S-PS supplementation does 
improve performance during, and recovery from, prolonged intermittent exercise. 
Future research could assess sprint performance in the 48 hours of recovery, as well 
as during prolonged intermittent exercise; this would allow researchers to quantify the 
effects of S-PS supplementation on performance during exercise, and performance 
recovery following it. Furthermore, future research could endeavour to ascertain if 
the ergogenic effects of S-PS are dose-dependant, by comparing a supplement with 
varying amounts of S-PS supplementation (for example 1000 mg-day*1 and 500 
mg-day' 1 for 1 0  days prior to exercise).
Moreover, future research is warranted to clarify if S-PS supplementation has any 
effect on the cortisol response to prolonged intermittent exercise. This may be 
achieved by experimenting with the supplementation routine, in order to clarify if the 
ability of S-PS to attenuate cortisol response to prolonged intermittent exercise is 
dose-dependant. Previous researchers have demonstrated higher doses of S-PS to be 
more effective in attenuating cortisol response; subsequently future research could 
focus on supplementing with varying doses of S-PS (for example 1000 mg-day' 1 and 
500 mg-day' 1 for 10 days prior to exercise). Additionally, future research could
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attempt to clarify whether or not S-PS supplementation has any effect on the 
elevation of oxidative stress associated with prolonged intermittent exercise, as this 
study was unable to do so. Future research could measure additional indirect markers 
of oxidative stress (for example malonaldehyde, MDA), or alternatively could use 
muscle biopsies to directly measure levels of pro-oxidants and antioxidants. 
Moreover, future research could measure oxidative stress during exercise (for 
example at half time), as this study only did so 2 0  min before and after exercise. 
Future research should attempt to control the amount of exercise across trials, so that 
the PS and placebo groups undergo the same exercise stress.
This study referred to previous research on soccer, the majority of which used 
professional soccer players as subjects. Consequently this study may be somewhat 
limited by the use of semi-professional (University) soccer players instead, as more 
profound responses to exercise have been demonstrated at higher levels. Therefore, 
future research may wish to use professional soccer players as subjects, where S-PS 
supplementation may be of clearest benefit, and any findings would be directly 
comparable with previous research on the demands of soccer match play. However, 
such work would require researchers to overcome the constraints posed by long 
periods of inactivity (for example for a minimum of 48 hours before and after 
exercise), and it remains to be seen if experimenting in the close season, or using non- 
first team players, might overcome such constraints.
Previous research has hypothesised upon the mechanisms by which supplementation 
with S-PS has attenuated the stress response to exercise; the common consensus is 
that S-PS regulates activation of the hypothalamo-pituitary-adrenal (HPA) axis,
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specifically by inhibiting the release of adrenocorticotropic hormone (ACTH) by the 
pituitary gland (which in turn inhibits cortisol release). However, these hypothesise 
remain inconclusive, and researchers are unclear how much orally administered S-PS 
reaches the blood stream and how much is lost in waste products. Consequently, 
future research could attempt to ascertain how much orally administered S-PS reaches 
the blood stream, and how quickly. Such research could be conducted independently 
of any exercise protocol, and could directly measure S-PS concentrations in blood, 
and waste products (for example urea), and muscle (for example by muscle biopsy).
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Appendix A -  Application for Ethical Approval
Application for Ethical Approval, 
Department of Psychology, University of Wales Swansea 
MPhil Project in Collaboration with the 
Department of Sports Science, University of Wales Swansea
All Project students should complete this form in consultation with their project supervisor.
If your supervisor feels that the project involves any potentially controversial procedures (i.e. 
they feel that the ethical issues raised need to be considered by the Department Ethics 
Committee) then the form should be placed in the tray in the Resources Centre for consideration 
by the Departmental Ethics Committee. Further advice will then be given to you by the Ethics 
Committee via your supervisor. The completed form should be bound along with your project 
report.
Project Title: The effects of chronic phosphatidylserine (PS) supplementation on recovery
following prolonged intermittent exercise.
Students Name: Daniel Wadsworth; BSc (Wales)
Supervisor: Mike Kingsley; MSc (Lough), BPhEd (Otago), PGCE (Wales)
Collaborator: Professor David Benton; PhD
Brief description of the purpose and methods of the project:
Purpose:
Phosphatidylserine (PS), has been shown to reduce blood levels of cortisol in response to 
resistance training (Fahey et al., 1998) and physical exercise (Monteleone et al., 1992). The 
elevation of cortisol levels in response to exercise stress leads to the accelerated catabolism of 
amino acids. As such, elevated cortisol levels can be viewed as a possible precursor to muscle 
damage. Subsequently, suppression of cortisol levels could theoretically prevent muscle damage, 
and therefore maintain muscle mass. Supplementation with PS may therefore enhance recovery 
following exercise. Burke (2000) supports the possible benefits on recovery >efc-PS
# rtS'r*'o
■rvypcnuiA
supplementation, suggesting that it may minimize muscle fibre damage caused by muscular 
stress.
Aims:
To investigate the effects of chronic phosphatidylserine (PS) supplementation, on heart rate and 
cortisol levels, during and immediately following intermittent exercise.
To investigate the effects of chronic phosphatidylserine (PS) supplementation on muscle 
soreness/damage following intermittent exercise.
No. o f participants'. 16-20
How and where are the participants to be recruited: Undergraduate and postgraduate male 
(student) volunteers from Swansea University.
Experimental procedure' (brief details only): Preliminary testing of subjects will include an 
estimation of maximal oxygen consumption (VC^ max), by multi-stage fitness test. Subjects will 
then complete a familiarization trial of a prolonged intermittent exercise protocol, designed to 
replicate the physiological demands of soccer match play. Subsequently, subjects will complete 
two further exercise trials, once with no supplement (control) (Tl) and once with either a (PS) 
supplement or a glucose placebo (T2). Chronic supplementation of 900 mg'day' 1 of PS (or 
placebo) will take place for 10 days prior to T2. Subjects will be randomly allocated to a placebo 
controlled double blind procedure. A minimum of 1 week will separate the familiarization and 
Tl trials, with T2 occurring approximately 4 weeks later.
During Tl and T2, physiological measurement procedures will consist of heart rate monitoring, 2 
venous blood samples (< 30 ml per sample), and sprint/endurance performance assessment. 
Subjects will be required to return for tests 1 and 2 days after exercise to assess recovery, when 
further blood samples (< 30 ml per sample) will be collected in order to assess their recovery 
(one sample each day), and muscle soreness assessed. Blood samples will then be analysed, and 
serum creatine kinase (CK) activity and serum myoglobin concentrations assessed, both of which 
are markers of muscle damage. Levels of cortisol within the blood will also be measured.
Details o f any payment given: None
Consent and Debriefing
Have you prepared a consent form for participants? YES (Appendix A)
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Have you prepared an information sheet to debrief participants? YES (Appendix B)
You must attach the consent form and information sheet before handing this form to your
supervisor. You must also attach a copy of any questionnaire(s) that you intend using:
Appendix C -  Environmental Validity Questionnaire;
Appendix D -  Perceived Muscle Soreness Questionnaire.
Ethical Considerations
Please read the following declarations carefully and detail below any ways in which your project 
deviates from them. Then sign where indicated.
1. I have ensured that there will be no active deception of participants.
2. I have ensured that no data will be personally identifiable.
3. I have ensured that no participant should suffer any undue physical or psychological
discomfort
4. I certify that there will be no administration of potentially harmful drugs, medicines or 
foodstuffs. *
5. I will obtain written permission from an appropriate authority before recruiting members of 
any outside institution as participants.
6 . I certify that the participants will not experience any potentially unpleasant stimulation or 
deprivation?
7. I certify that any ethical considerations raised by this proposal have been discussed in detail 
with my supervisor.
8 . I certify that the above statements are true with the following exception(s):
* (4) - See Appendix E (Safety information)
Student’s signature: Date:
In the supervisor’s opinion, this project (tick one only):
Does not raise any significant issues.
Raises some ethical issues, but I consider that appropriate steps and precautions have been taken
and I have approved the proposal and accept the responsibility for having done so.
Raises ethical issues that need to be considered by the Departmental Ethics Committee.
Raises ethical issues such that it should not be allowed to proceed in its current form.
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Supervisor’s signature: Date:
(For Ethics Committee use only)
The ethical issues raised by this project have been considered by members of the Departmental 
Ethics Committee who made the following comments:
Please ensure that you take account of these comments and prepare a revised submission that 
should be shown to your supervisor/ resubmitted to the Department Ethics Committee (delete as
appropriate).
Signed: Date:
(Chair, Departmental Ethics Committee)
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I
PSYCHOLOGY
DEPARTMENT
ETHICS COMMITTEE
Memo
*
To: Professor David Benton
From Professor David Clark, Chair o f Departmental Ethics Committee 
Date: 19* March, 2003
Re: Im pact of phosphatidylserine (PS) on recovery following exercise
Members of the departmental Ethics Committee have now reviewed the above study and 
agree that it raises no substantive ethical issues, provided the information obtained from the 
questionnaires is kept absolutely confidential and that no personally identifiable information is 
entered on computer. You may therefore proceed with your study.
•  Page2
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Appendix B -  Subject Information Sheet
DEPARTMENT OF SPORTS SCIENCE 
SUBJECT INFORMATION SHEET
21st February 2003. Version 1.0 
Contact Details:
Daniel Wadsworth, department o f Sports Science.
Contact: 07779088153
1. Study title
The effects of chronic phosphatidylserine (PS) supplementation on recovery following 
prolonged intermittent exercise.
2. Invitation paragraph
You are being asked to volunteer as a subject for this study, which is being conducted for 
MPhil research.
3. What is the purpose of this study?
This study aims to investigate the effects of chronic supplementation of PS on recovery. 
The short-term effects (immediately after exercise) of supplementation on heart rate and 
cortisol levels will be investigated, as will the long-term (up to 48 hours post exercise) 
effects on muscle soreness and damage.
4. Why have I been chosen?
You have been chosen as a subject for this study as you are an active male, aged 18-25  
years old. Your participation in this study is entirely voluntary, and you should be aware 
that you have the right to withdraw at any time without a reason.
5. What will happen to me if I take part?
Preliminary testing will consist of a multi-stage fitness test (the ‘bleep test’) in order to 
assess your fitness. After this, you will complete an exercise protocol designed to 
simulate the activity levels and demands of a soccer match. The protocol consists of 90 
minutes of walking, jogging, cruising and sprinting, and also includes frequent rest 
periods (1 minute breaks) and a 15 minute ‘half-time’.
You will need to complete this protocol on 3 separate occasions, the first trial will 
familiarize you with the protocol. You will then complete two further trials, once with no 
supplement (control) (Tl) and once with either a (PS) supplement or a glucose placebo 
(T2). You will be supplemented with either 900 mg day"1 of PS or a glucose placebo for 
10 days prior to T2.
During Tl and T2, physiological measurement procedures will consist of heart rate 
monitoring and sprint/endurance performance assessment Before and after Tl and T2
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blood will be taken intravenously, (< 30 ml per sample). You will be required to return 
for tests 1 and 2  days after exercise to assess your recovery, when further blood samples 
will be collected (one each day), and your soreness will be assessed (by questionnaire).
You will be required to control your diet 24 hours prior to Tl and T2, and in the two 
days following each trial (Tl and T2). You will also be required to do no exercise 24 
hours before Tl and T2, and in the two days following each trial.
6. What are the possible disadvantages of taking part?
As the study aims to assess the effects of PS supplementation with regards to muscle 
soreness, subjects are expected to feel some degree of discomfort on the days following 
the exercise.
Blood samples are to be taken intravenously by a trained individual, and whilst this is not 
a painful process, subjects must be comfortable with such collection methods. Even 
though the volume of blood taken is small (< 30 ml per sample) there exists the 
possibility that during or immediately following this procedure subjects may feel light 
headed or faint. There is an extremely small risk that this procedure could result in an air 
or plastic embolism, but good practice minimises the risk. In addition, every effort will 
be made to minimise the risks of contaminating the wound by using sterile disposable 
equipment and standardised procedures for the collection and disposal of biohazard 
wastes.
7. What are the possible benefits of taking part?
Taking part in this study will allow you to assess your fitness at the time of the study, and 
also follow your progress throughout the duration of the study. It has been shown that PS 
improves confidence and composure during exercise, which is clearly of benefit. In 
addition, PS enhances perceived well-being following exercise, and also reduces 
perceived soreness following exercise. As such, PS can be said to enhance your recovery 
from exercise, and therefore has possible benefits on future exercise bouts.
8. Will my taking part in the study be kept confidential?
Whilst the study will be available to all within the University of Wales Swansea, all 
results from this study will remain anonymous.
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Appendix C -  Subject Consent Form
DEPARTMENT OF SPORTS SCIENCE 
SUBJECT CONSENT FORM
Contact Details:
Daniel Wadsworth, department of Sports Science
Project Title:
The effects of chronic phosphatidylserine (PS) supplementation on recovery 
following prolonged intermittent exercise.
I confirm that I have read and understood the information sheet dated
 / ......./ ....... (version number................................. ) for the above
study and have had the opportunity to ask questions.
Please initial box 
□
2. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical 
care or legal rights being affected.
□
3. I understand that sections of any of data obtained may be looked
at by responsible individuals from the University of Wales Swansea or __
from regulatory authorities where it is relevant to my taking part in |__ |
research. I give permission for these individuals to have access to 
these records.
4. I agree to take part in the above study.
Name of Subject Date Signature
Name of Person taking consent Date Signature
Researcher Date Signature
108
Appendix D
Appendix D
ACSM Health/fitness preparticipation screening questionnaire
AHA/ACSMHealth/Fitness F acility Preparticipation Screening Questionnaire,
Name
Address
Phone num ber home work
Emergency contact name 
phone
Date of birth
History Assess your health needs by marking all true statements.
You have had:
□a heart attack
□heart surgery
□cardiac catheterization If you marked any ofthe statements
□coronary angioplasty (FI'CA) in this section, consult you a health
□pacemaker/implantable cardiac provider before engaging in exercise.
defibrihatar/rhythm disturbance You may need to use a facility with a
□heart valve disease * medically qualified staff.
□heart Mure
□heart transplantation
□congenita] heart disease
Symptoms and other health issues:
□You experience chest discomfort with exertion.
□You experience unreasonable breathlessness.
□You experience dizziness, feinting, blackouts.
□You take heart medications.
□You take prescription medication®.
□You have musculoskeletal problems.
□You have concerns about the safety of exercise.
□You are pregnant
Cardiovascular risk factors
□You arc a man older than 45 years.
□You are a woman older than 55 years or you have had a
hysterectomy or you are postmenopausal
□You sracike. If you marked two or more
□Your Wood pressure is greater than 140/90. of the statements in this
□You don't know your blood pressure. section, you should consult
□You take blood pressure medication. your healthcare provider
□Your Wood cholesterol level is >240 mg/dL before engaging in exercise.
□You don't know your cholesterol level. You might benefit by using a
□You have a Wood relative who had a heart attack facility with professionally
before age 55 (father or brother) or age 65 (mother or sister). qualified exercise stiff'to
□You are diabetic or take medicine to control your Wood sugar guide your exercise program.
□You are physically inactive (i.e., you get less than 30 minutes
of physical activity on al least 3 days per week).
□You are mere than 20 pounds overweight
□None of the above is true.
You should be able to exercise safety without consulting your healthcare provider in
almost any facility that meets your exercise programme needs.
AHA'ACSM indicates American Heart Association/American College of Spots Medicine.
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Appendix E -  Set Warm-up
i
■ Jog 6  lengths of the hall (20 m each)
■ Sprint 3 lengths of the hall (20 m each)
■ Circle each ankle both ways 5 times each
■ Calf stretch -  1 leg forward, with feet parallel, put weight on front foot,
holding for 8  sec on each leg
■ Quadriceps -  Hold foot behind body, pulling into buttocks. Push hips forward,
holding for 8  sec on each leg
■ Hamstrings -  1 leg forward, bend the other knee slightly. Stick behind out,
with foot remaining on floor. Do not lift toe, hold for 8  sec on each leg
■ Side stretch -  Bend towards other side, running arm down leg. Do not lean 
forwards, hold for 8  sec on each side
■ Triceps -  Holding arm across chest, hold for 8  sec on each arm
■ Back -  make a circle in front of the body with the arms (as if hugging a tree!). 
Curl back, holding for 8  sec
■ Arms -  Rotate arms at the same time, trying to brush ears. 1 arm forwards, 1 
arm backwards, 5 times each way
■ Neck -  Tilt head to each side (ear to shoulder), do not pull neck. Hold for 8  
sec each side
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Appendix F - Perceived Muscle Soreness Questionnaire.
Subject: Date:
> Rate general (overall) muscle soreness on this scale:
0 1 2 3 4 5 6 7 8 9  10
where:
0 — No soreness 6 - Sore
2 — Light soreness 8 -  Very sore
4 — Somewhat sore 10 — Extreme soreness
>  Rate actual areas of soreness (on the scales):
Neck and Shoulders 0 1 2 3 4 5 6 7 8 9 10
Chest 0 1 2 3 4 5 6 7 8 9 10
Upper limbs 0 1 2 3 4 5 6 7 8 9 10
Trunk (and abdominals) 0 1 2 3 4 5 6 7 8 9 10
Back 0 1 2 3 4 5 6 7 8 9 10
Quadriceps 0 1 2 3 4 5 6 7 8 9 10
Gluteals 0 1 2 3 4 5 6 7 8 9 10
Hamstrings 0 1 2 3 4 5 6 7 8 9 10
Calves 0 1 2 3 4 5 6 7 8 9 10
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Appendix G -  Borg RPE scale
7 Very, very light
8
9 Very light
10
11 Fairly light
12
13 Somewhat hard
14
15 Hard
16
17 Very hard
18
19 Very, very hard
20
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Appendix H -  Ecological Validity Questionnaire.
Subject: Date:
> ‘The exercise protocol provides an excellent replication of soccer match- 
play.’ To what extent do you agree with this statement?
■ Strongly disagree
■ Disagree
■ Neither agree nor disagree
■ Agree
■ Strongly agree
> Indicate the extent to which you agree with each of the statements about 
the protocol listed below.
Where:
1 - Strongly disagree
2 - Disagree
3 - Neither agree nor disagree
4 - Agree
5 - Strongly agree
‘Too much turning’
‘Too much sprinting’
‘Not enough match-skills’
‘The protocol was significantly easier 
than a soccer match'
‘Too much walking’
‘Too little backwards movement’ 
‘Too much jogging’
‘Too frequent rest periods/breaks’ 
‘Rest periods/breaks were too short’
2 3 4 5
2 3 4 5
2 3 4 5
2 3 4 5
2 3 4 5
2 3 4 5
2 3 4 5
2 3 4 5
2 3 4 5
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Appendix I -  Raw Data
Appendix I (i) Temperature & Humidity (all trials)
Subject Temp Temp Humidity Humidity
T1 T2 T1 T2
1 2 1 2 1 58 64
2 2 1 2 1 58 64
3 19 19 51 46
4 19 19 51 46
5 23 2 2 44 67
6 23 2 2 44 67
7 16 19 44 53
8 16 19 44 53
9 18 2 2 42 52
1 0 18 2 2 42 52
1 1 2 0 2 2 49 53
1 2 2 0 2 2 49 53
13 2 0 23 53 45
14 2 0 24 53 50
15 2 0 23 63 45
16 2 0 2 2 63 52
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Appendix I (ii) Subject Data
Subject Trial
RPE 
% time PST
Weight (kg) 
PE PST
Weight loss 
(kg) MSFT
dec
MSFT
1 1 14 19 80.6 79.5 -1 . 1 8-4 8.37
2 1 1 19 80 79 - 1 8 - 8 8.73
2 1 1 2 19 80.7 80.8 0 . 1 10-7 10.64
2 1 1 2 0 82.5 82.8 0.3 11-3 11.25
3 1 1 2 2 0 79 78.4 -0 . 6 1 2 - 1 12.08
2 13 2 0 78.5 78 -0.5 12-4 12.33
4 1 16 18 77.6 77.5 -0 . 1 9-5 9.45
2 18 19 79.5 78.6 i o vo 8 - 2 8.18
5 1 14 18 75 75.1 0 . 1 1 2 - 0 1 2 . 0 0
2 17 19 75.4 75.5 0 . 1 13-0 13.00
6 1 17 2 0 78.2 77 -1 . 2 14-2 14.15
2 17 2 0 78 76.6 -1.4 14-6 14.46
7 1 13 19 67.8 67 -0 . 8 10-5 10.45
2 13 19 69 67.6 -1.4 1 1 - 0 1 1 . 0 0
8 1 13 18 71 69.8 -1 . 2 1 1 - 0 1 1 . 0 0
2 14 17 69.6 68.7 -0.9 1 1 - 0 1 1 . 0 0
9 1 14 16 8 8 87 - 1 1 1 - 2 11.17
2 13 15 86.7 85.4 -1.3 1 1 - 6 11.50
1 0 1 14 17 60.2 58.1 -2 . 1 10-3 10.27
2 14 15 60.2 58.3 -1.9 1 1 - 0 1 1 . 0 0
1 1 1 13 15 8 8 86.5 -1.5 1 0 - 1 10.09
2 1 2 15 87.5 85.8 -1.7 10-4 10.36
1 2 1 15 15 82 81.7 -0.3 1 0 - 1 10.09
2 9 1 2 81.8 81.2 -0 . 6 8 - 1 0 8.91
13 1 15 18 87.2 87 -0 . 2 1 0 - 0 1 0 . 0 0
2 15 16 87.3 87.3 0 8-4 8.37
14 1 14 18 74 74 0 15-0 15.00
2 13 19 76.2 75.4 -0 . 8 15-0 15.00
15 1 1 2 17 85 84.5 -0.5 13-0 13.00
2 13 18 84.4 84.1 -0.3 14-0 14.00
16 1 1 2 16 71.2 71.5 0.3 1 1 - 1 0 11.83
2 13 16 71.4 71 -0.4 8 - 1 0 8.91
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Appendix I (iii) Heart Rate Data
Subject Trial Heart Rate (HR)
Av max h/t av av (no h/t) av (no MSFT) av (no both)
1 1 172.08 215.00 127.87 180.01 169.89 178.29
2 166.68 213.00 1 2 2 . 1 1 174.68 164.34 172.78
2 1 141.59 2 0 0 . 0 0 96.18 149.56 138.00 146.36
2 132.31 2 0 1 . 0 0 86.28 140.33 128.42 136.85
3 1 132.04 191.00 88.85 139.67 127.91 135.98
2 135.90 198.00 95.22 143.48 131.96 139.88
4 1 163.11 198.00 116.92 171.38 160.77 169.59
2 159.77 195.00 112.84 168.28 158.12 167.08
5 1 145.39 196.00 95.00 154.07 142.11 151.53
2 142.20 199.00 91.78 150.87 138.45 147.79
6 1 133.23 184.00 96.49 139.42 129.22 135.77
2 132.17 185.00 95.73 138.29 128.05 134.51
7 1 155.58 205.00 105.18 164.66 151.64 161.25
2 151.58 205.00 105.77 159.60 148.03 156.49
8 1 146.76 191.00 100.34 154.97 143.49 152.19
2 140.81 191.00 99.93 150.32 137.90 145.49
9 1 132.62 189.00 90.09 140.29 130.34 138.72
2 129.72 193.00 82.72 137.91 126.30 135.02
1 0 1 151.72 203.00 110.63 159.00 148.55 156.14
2 143.70 2 0 1 . 0 0 100.42 151.29 140.11 148.05
1 1 1 156.95 199.00 106.72 165.79 153.86 163.19
2 154.81 191.00 120.56 160.94 152.91 159.38
1 2 1 153.70 199.00 107.57 162.43 150.82 160.25
2 162.10 2 0 1 . 0 0 125.92 168.50 159.72 166.48
13 1 130.55 186.00 90.56 137.61 127.48 134.87
2 137.28 182.00 1 0 0 . 0 0 144.02 135.38 142.45
14 1 110.67 184.00 63.23 118.57 110.67 111.77
2 100.51 179.00 58.38 107.46 93.31 100.30
15 1 132.79 2 0 0 . 0 0 88.73 140.30 127.79 135.61
2 126.04 2 0 0 . 0 0 82.37 133.42 119.61 127.05
16 1 144.30 2 0 0 . 0 0 104.37 n/a 135.18 150.28
2 151.12 194.00 113.18 157.90 148.25 155.26
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Appendix I (viii) Creatine Kinase T1
Subject___________Creatine Kinase (CK)
PE PST reel rec2
1 117 290 656 307
2 395 589 959 682
3 651 760 1339 724
4 144 308 1418 8 8 8
5 643 851 1 1 0 0 698
6 523 6 6 6 466 398
7 149 241 224 262
8 166 307 366 345
9 194 375 585 360
1 0 385 578 387 248
1 1 127 2 2 0 473 275
1 2 142 319 809 369
13 464 633 867 468
14 637 976 613 281
15 307 525 406 361
16 313 419 288 175
Appendix I (ix) Creatine Kinase T2
Subject__________ Creatine Kinase (CK)
PE PST 24 Hr 48 H r
1 160 308 411 193
2 395 650 6 6 6 568
3 862 1 0 2 2 959 516
4 194 302 377 242
5 199 401 509 358
6 286 464 404 397
7 159 275 213 128
8 1 2 0 245 516 422
9 204 408 867 518
1 0 206 311 306 213
1 1 83 188 318 218
1 2 2 0 2 367 440 224
13 164 467 354 397
14 209 288 198 371
15 104 252 284 226
16 137 239 295 198
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Appendix I (x) Cortisol and HPO (all trials)
Subject Trial CORTISOL (nmol/1) HPO(uM)
PE PST reel rec2 PE PST reel rec2
1 1 470 783 245 250 0.784 0.919 1.149 0.837
2 387 365 275 258 0.858 1.059 0.893 0.322
2 1 407 647 273 322 0.594 0.746 0.799 0.586
2 403 559 257 305 0.674 0.724 0.992 0.712
3 1 295 NS 311 325 0.631 0.818 0.763 0.801
2 368 508 232 2 0 2 0.362 0 . 8 8 8 0.834 0.274
4 1 359 739 273 529 1.071 1.244 0.813 1.019
2 454 391 326 286 0.731 0.862 0.950 0.884
5 1 384 425 290 263 1.004 1.078 0.903 0.922
2 447 600 589 444 0.717 0.850 0.963 0.610
6 1 355 322 306 292 1.104 1.439 1.028 0.778
2 431 462 311 263 0.716 1.219 1.061 1.063
7 1 308 455 143 235 1 . 0 2 2 1 . 1 0 0 0.892 0.880
2 369 454 209 231 0.801 0.990 0.747 1.418
8 1 441 571 307 416 0.894 0.928 0.811 0.778
2 468 643 NS 238 0.829 0.832 1 . 0 2 1 0.907
9 1 356 365 254 242 0.849 0.842 0.943 1 . 1 0 0
2 270 467 291 272 0.923 1.131 0.983 1.074
1 0 1 NS 585 499 518 0.783 0.957 0.832 0.834
2 489 422 271 536 0.862 0.913 0.762 0.898
1 1 1 489 568 216 180 0.970 1.163 0.870 0,890
2 485 701 204 354 0.940 1.251 0.930 0.829
1 2 1 NS 632 347 314 0.752 1 . 2 0 2 1.007 0.864
2 583 NS 484 336 0.846 1.098 0.968 0.871
13 1 417 282 243 271 1 . 2 2 1 1.209 0.784 NS
2 141 244 177 138 1.046 1.314 0.996 1.340
14 1 408 581 361 334 0.884 0.861 0.783 0.706
2 463 442 233 262 0.860 1.154 1 . 1 1 1 0.940
15 1 397 646 382 296 1.109 1.420 1.176 0.887
2 265 558 287 279 0.966 1.296 0.983 1.084
16 1 383 545 2 1 2 299 0.797 0.876 0.709 1.177
2 455 492 226 307 1.189 1.376 0.756 0.809
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Appendix I (xi) Vitamin C and E (all trials)
Subject Trial__________VITAMIN C (uM)_____________ VITAMIN E (alpha-toc.)
PE PST reel rec2 PE PST reel rec2
1 1 6 . 0 27.8 31.0 37.4 26.45 29.55 27.75 26.24
2 23.6 44.4 33.3 36.9 26.06 27.87 27.93 22.79
2 1 0 . 0 1 1 . 2 13.8 2 0 . 0 31.67 32.05 27.74 30.23
2 NS 1 1 . 8 8 . 1 14.7 25.90 30.57 30.10 31.66
3 1 NS 32.9 63.7 53.8 28.52 30.56 27.45 28.46
2 44.7 67.8 37.1 39.1 32.80 32.15 31.15 28.89
4 1 73.5 85.2 63.8 6 8 . 0 26.05 27.84 23.92 25.14
2 53.6 72.4 60.0 41.8 26.12 27.20 29.63 28.15
5 1 1 . 2 65.6 40.8 39.1 22.28 23.15 23.18 22.91
2 NS 38.5 43.9 40.7 2 1 . 0 0 23.88 22.81 22.46
6 1 6 . 1 26.3 7.9 45.5 33.33 36.17 32.41 28.97
2 20.7 53.1 30.7 57.0 31.22 34.50 32.56 32.74
7 1 60.3 71.3 48.9 45.1 19.56 20.18 20.46 19.73
2 17.1 30.8 30.4 16.2 16.84 22.93 29.19 29.47
8 1 43.0 57.6 42.7 47.5 30.03 27.34 24.25 22.34
2 49.2 64.4 43.7 43.2 24.00 25.62 24.42 24.33
9 1 3.7 1 0 . 0 13.2 30.9 25.77 24.03 25.38 22.42
2 1 0 . 8 17.5 10.9 52.9 24.25 25.55 23.83 19.33
1 0 1 32.0 49.8 40.8 46.2 28.81 31.33 33.76 26.57
2 1 . 8 48.2 1.3 27.4 25.88 31.22 28.87 24.89
1 1 1 23.4 29.9 51.6 27.1 21.04 27.23 23.20 30.40
2 7.6 4.7 19.5 49.9 28.97 26.71 17.74 26.81
1 2 1 54.0 57.2 56.0 51.0 26.63 31.54 25.87 26.67
2 4.4 41.0 44.8 36.9 27.66 28.89 28.67 29.01
13 1 NS 32.9 63.7 53.8 29.25 32.58 27.48 29.25
2 44.7 67.8 37.1 39.1 35.98 33.86 31.14 38.50
14 1 29.1 32.9 60.0 54.4 23.11 21.03 21.45 19.45
2 49.1 42.3 35.7 38.9 21.92 21.59 22.93 23.79
15 1 14.8 46.4 67.3 69.7 25.00 27.22 20.33 22.83
2 35.5 35.3 34.2 35.9 27.67 30.49 27.84 25.34
16 1 0 . 2 47.6 56.2 70.0 29.43 29.17 29.16 32.74
2 26.1 39.6 38.8 35.8 34.07 38.99 27.69 27.70
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Appendix I (xii) Sprint Times (all trials)
Subject Trial Mean time mean vel Peak time Peak vel
1 1 2.72 5.51 2.59 5.79
2 2 . 6 8 5.61 2.58 5.81
2 1 2.72 5.51 2.55 5.88
2 2.62 5.72 2.45 6 . 1 2
3 1 2.58 5.81 2.51 5.98
2 2.47 6 . 1 0 2.32 6.47
4 1 2.44 6.15 2.36 6.36
2 2.65 5.65 2.31 6.49
5 1 2.50 5.99 2.34 6.41
2 2.49 6 . 0 2 2.38 6.30
6 1 2.49 6.03 2.39 6.28
2 2.44 6.15 2.3 6.52
7 1 2.95 5.08 2.84 5.28
2 2.87 5.24 2.75 5.45
8 1 2.87 5.22 2.75 5.45
2 2.72 5.52 2.65 5.66
9 1 2.62 5.73 2.52 5.95
2 - - - • -
1 0 1 3.01 4.98 2.89 5.19
2 - - - -
1 1 1 - - - -
2 - - - -
1 2 1 - - - -
2 - - - -
13 1 2.65 5.66 2.3 6.52
2 2.54 5.91 2.4 6.25
14 1 2.61 5.76 2.32 6.46
2 2.46 6 . 1 0 2.3 6.52
15 1 2.56 5.85 2.48 6.05
2 2.50 6 . 0 1 2.39 6.28
16 1 2 . 6 8 5.60 2.62 5.72
2 2.82 5.32 2.46 6 . 1 0
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Appendix I (xiii) Perceived General Muscle Soreness (all 
trials)
Subject Trial General Soreness
PE PST 24 Hr 48 Hr
1 1 0 2 4 2
2 1 0 2 4 2
3 1 2 4 3 1
4 1 2 6 6 4
5 1 7 7 2 1
6 1 5 6 4 4
7 1 1 4 2 3
8 1 1 6 3 3
9 1 3 4 2 1
1 0 1 4 6 2 2
1 1 1 1 1 3 1
1 2 1 0 3 4 0
13 1 5 6 6 3
14 1 4 6 6 3
15 1 1 2 1 0
16 1 5 5 5 3
1 2 0 1 2 1
2 2 4 4 2 1
3 2 3 6 3 2
4 2 1 3 4 2
5 2 0 2 0 0
6 2 0 0 2 0
7 2 2 3 5 2
8 2 1 2 2 1
9 2 1 2 2 1
1 0 2 1 4 4 3
1 1 2 0 3 4 2
1 2 2 1 7 2 1
13 2 2 5 3 2
14 2 0 3 1 0
15 2 2 2 2 1
16 2 0 4 4 3
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